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Abstract 
Because endometriosis is considered to be the primary cause of infertility in women and 
the diagnosis is known to be delayed by many years, it is important to understand the 
association between endometriosis and infertility. The purpose of this cross-sectional, 
secondary data analysis study was to determine whether there was an association between 
the age of women when diagnosed with endometriosis and infertility. Using the general 
model of total patient delay (i.e., the Andersen model) as a theoretical foundation, data 
for this study was collected by assessing patient medical records of women with 
endometriosis at multiple OB-GYN clinics in Eastern North Carolina. Multiple logistic 
regression was conducted to determine potential association between variables. The 
results presented that diagnosis at an older age and presence of uterine fibroids are 
significant risk factors for infertility among women with endometriosis. From the results, 
it can be concluded that infertility may be preventable in women diagnosed with 
endometriosis and uterine fibroids in younger age. This study presents positive social 
change by preventing infertility amongst women who suffer from both endometriosis and 
uterine fibroids; potentially creating preventative programs aimed at better educating 
women on the risks of endometriosis and uterine fibroids (especially when presented 
together).   
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Chapter 1: Introduction to the Study 
Introduction 
A diagnosis of endometriosis has been found to be delayed anywhere from 7-10 
years and is often not recognized by physicians in practice, leading to misdiagnosis 
and/or suboptimal care (Johnston, Reid, & Hunter, 2015). Investigation concerning 
causes of female infertility is receiving less attention; although, there are optimal 
approaches to managing infertility that require a method associated with routine and 
timely measures (Bell, 2014). Earlier diagnosis of the disease (e.g., diagnosis at an earlier 
age) could serve as a preventative strategy towards infertility. If a statistically significant 
association between age of women when diagnosed with endometriosis and infertility is 
determined, beliefs that suppressive medical treatment does not benefit fertility 
(American Society for Reproductive Medicine, 2012) could be proven false, which could 
lead to fewer incidences of endometriosis-related infertility. Furthermore, determining a 
statistically significant association also could provide for more effective patient/doctor 
visits for women who suffer from common symptoms of endometriosis. 
Although suppressive medical treatment of endometriosis does not benefit 
fertility, the age of a woman when diagnosed with endometriosis has not been taken into 
consideration (American Society for Reproductive Medicine, 2012). Determining 
diagnosis at an earlier age can serve as a preventative strategy against infertility. In this 
study, I contributed to the literature on women’s health by determining whether age of 
women, when diagnosed with endometriosis, is associated with higher and lower 
incidences of infertility.  
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The findings of the study might lead to social change by adding new evidence to a 
topic within women’s health that has been considered a controversial topic (Kovacs, 
2015). The findings of the study are expected to provide information on existing 
information and theories about the disease that are false/misleading. The study is may 
provide information that may help individuals recognize and understand normal 
menstrual cycles versus abnormal menstrual cycles, as well as normal symptoms 
associated with menstrual cycles versus abnormal pain that can be linked to 
endometriosis. The study may also provide physicians with more information about 
prompt endometriosis diagnoses. Furthermore, the study may provide support for women 
who suffer from the disease. Women should be made aware that effective treatment is 
available if they seek it. Last, the study is expected to promote social change by further 
highlighting the effects of endometriosis that affect women and their families because the 
disease currently is not recognized as a medical disability (Jones, 2016). 
Endometriosis may go undiagnosed for anywhere from 7-10 years, and 
endometriosis is associated with infertility (Johnston, Reid, & Hunter, 2015). Because 
there currently are no existing studies on the potential association between the age of 
women when diagnosed with the disease and infertility, the results of this study might aid 
in the development of better precautionary methods for avoiding infertility while living 
with endometriosis. 
Background 
Suppressive medical treatment of endometriosis does not increase fertility; yet, 
the age of women when diagnosed with the disease never has been taken into 
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consideration when assessing infertility rates amongst women diagnosed with the disease 
(American Society for Reproductive Medicine, 2012; Radhika, Chawla, Nanda, Yadav, 
& Radhakrishnan, 2016). Radhika et al. (2016) found that 73% of patients had moderate 
to severe endometriosis (age groups: <20, 21-30, >30 – with average age of participants 
being 29.6 years) with 31.46% of the participants classified as being infertile. 
Furthermore, correlations between stages and infertility per age have never been 
examined (Radhika et al., 2016). This study was needed in order to increase the 
understanding the association between endometriosis and infertility, especially in regards 
to how the age in which a woman is diagnosed with the disease might affect her ability to 
conceive.  
Scholars have examined the process associated with diagnosing endometriosis, 
the sites inside a woman’s body where endometriosis can occur, the impact endometriosis 
has on the lives of women and their families, the treatment for endometriosis, the 
potential link between endometriosis and infertility, and the potential impact uterine 
fibroids may have on women diagnosed with endometriosis. Although pregnancy rates 
for patients with endometriosis range from 24%-54%, estimated rates may be 
overestimated (Burghaus et al., 2016). Overlapping symptoms commonly associated with 
endometriosis should alert physicians to seek measures that aid in the formal diagnosis of 
the disease (Fauconnier et al., 2013). Furthermore, endometriosis poses detrimental 
impacts on women’s lives due to negative effects on marital/sexual relationships, social 
life, and physical and psychological wellbeing (Moradi, Parker, Sneddon, Lopez, & 
Ellwood, 2014). Patients who suffer from endometriosis might also suffer from uterine 
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fibroids, potentially increasing their chances of infertility (Uimari, Jarvela, & Ryynamen, 
2011).  
 The purpose of this study was to determine whether there was an association 
between the age of a woman upon diagnosis of the disease and infertility. Earlier 
diagnosis of the disease (e.g. diagnosis at an earlier age) could serve as a preventative 
strategy towards infertility. If a statistically significant association between age of women 
when diagnosed with endometriosis and infertility is determined, there could be fewer 
incidences of endometriosis-related infertility. Furthermore, determining a statistically 
significant association also could provide for more effective patient/doctor visits for 
women who suffer from common symptoms of endometriosis. 
Problem Statement 
Endometriosis is the primary cause of infertility in the United States, having a 
prevalence of 0.5%-5% in fertile women and 25%-40% in infertile women (Juneau 
Biosciences, 2016). The management of endometriosis-associated infertility, however, is 
unknown (Dunselman et al., 2014). There is a connection between infertility and 
endometriosis; however, the association between the two still remains uncertain 
(American Society for Reproductive Medicine, 2012). The longer that endometriosis goes 
undiagnosed, the more damage it can do; yet, there are few early diagnoses of the disease 
because many physicians are unaware of the common symptoms associated with the 
disease (Levett, 2016). Some patients have claimed that they visit their doctor with 
symptoms of lower abdominal and pelvic pain (common symptoms of endometriosis) 
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only to receive no support from physicians aside from receiving a prescription for opioids 
(i.e., painkillers; Johnston et al., 2015).  
Diagnosis of endometriosis among women has been found to be delayed 
anywhere from 7-10 years and is poorly recognized by physicians in practice, leading to 
misdiagnosis and/or suboptimal care (Johnston et al., 2015). Investigation concerning 
causes of female infertility is receiving less attention; although, there are optimal 
approaches to managing infertility that require a method associated with routine and 
timely measures (Bell, 2014). Earlier diagnosis of the disease (e.g., diagnosis at an earlier 
age) could serve as a preventative strategy towards infertility. If a statistically significant 
association between age of women when diagnosed with endometriosis and infertility is 
determined, beliefs that suppressive medical treatment does not benefit fertility 
(American Society for Reproductive Medicine, 2012) could be proven false, which could 
lead to fewer incidences of endometriosis-related infertility. Furthermore, determining a 
statistically significant association also could provide for more effective patient/doctor 
visits for women who suffer from common symptoms of endometriosis. 
Purpose of Study 
The purpose of the study was to determine whether an association exists between 
the time in which a woman is diagnosed with endometriosis (i.e., age of woman when 
diagnosed) and infertility. To address this gap, I used a quantitative research method. I 
assessed a potential association between variables to address the lack of knowledge that 
exists in regards to the association between endometriosis and infertility and how the age 
in which a woman is diagnosed with the disease might affect her ability to conceive. The 
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independent variable for this study was age, which described the age in which a woman 
was formally diagnosed with endometriosis. The dependent variable for this study 
consisted of infertility, which described whether or not a woman was considered to be 
unable to conceive. The variables site/implantation and uterine fibroids also were used as 
potential confounders affecting the association between age upon diagnosis of 
endometriosis and infertility. 
Research Questions and Hypotheses 
RQ1: What is the association between infertility and age of women when 
diagnosed with endometriosis after controlling for history of uterine fibroids? 
(H01): There is no statistically significant association between infertility and age 
of women when diagnosed with endometriosis after controlling for history of uterine 
fibroids. 
(H11): There is a statistically significant association between infertility and age of 
women when diagnosed with endometriosis after controlling for history of uterine 
fibroids. 
RQ2: What is the association between infertility and age of women when 
diagnosed with endometriosis after controlling for the specific sites of endometriosis? 
(H02): There is no statistically significant association between infertility and age 
of women when diagnosed with endometriosis after controlling for the specific sites of 
endometriosis. 
7 
 
(H12): There is a statistically significant association between infertility and age of 
women when diagnosed with endometriosis after controlling for the specific sites of 
endometriosis. 
Theoretical Foundation 
The theoretical framework for this study consisted of the general model of total 
patient delay, also known as the Andersen model, which is used for a variety of disorders 
(Walter, Webster, Scott, & Emery, 2012). The Andersen model was developed by 
Andersen in 1968 (Andersen & Newman, 1973). Reducing diagnostic delays may result 
in improved prognosis for most disorders (Walter et al., 2012). The Andersen model is 
used to explain aspects regarding delay stages (e.g., appraisal, illness, behavioral, 
scheduling, treatment) and was used in this study as a means to test whether diagnosis of 
endometriosis might pose a higher incidence for risk (i.e., infertility) based on age. The 
model also aided in explaining why certain time intervals exist between onset of 
symptoms of endometriosis and formal diagnosis. According to the Anderson model, 
diagnostic delay results from conceptual beliefs about a person’s symptoms; behavioral 
factors, such as strategies for self-appraisal; and techniques for coping with illness and 
emotional reaction (Walter et al., 2012). Such topics will be explained in further detail in 
Chapter 2. 
Nature of Study 
I used the quantitative approach in this study. Quantitative research was 
appropriate in determining whether there was a statistically significant association 
between age of women when diagnosed with endometriosis and infertility, as descriptive 
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quantitative researchers establish associations between variables (Creswell, 2013). 
Furthermore, because uterine fibroids and endometriosis may be associated with each 
other, the history of uterine fibroids may have an association with the age of women 
when diagnosed with endometriosis and infertility (Nezhat et al., 2016; Uimari et al., 
2011). I used a cross-sectional design with the use of secondary data analysis of existing 
medical records. In regard to statistical methods, I used multiple logistic regression and 
crosstabulation to assess potential association between variables. Age acted as the 
independent variable, and infertility acted as the dependent variable. 
Definitions 
Age: The number of years from birth of the respondent to the date when she was 
formally diagnosed with endometriosis.  
Endometriosis: The presence of endometrial glands or stroma in sites other than 
the uterine cavity (Jacobson et al., 2016). 
Formal diagnosis: Endometriosis confirmed by laparoscopic procedure. 
Infertility: Failure to achieve a successful pregnancy after 12 months or more of 
regular, unprotected sexual intercourse (Mascarenhas, Cheung, Mathers, & Stevens, 
2012).  
History of uterine fibroids: Having documentation by a physician concerning the 
presence of uterine fibroids on the uterus.  
Laparoscopic procedure: Minimal invasive surgery where a slender viewing 
instrument (laparoscope) is inserted through a small incision near the naval for diagnosis 
and/or removing endometrial tissue through another small incision (Mayo Clinic, 2016). 
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Site and location of endometriosis: The part of the female anatomy where the 
endometriosis is implanted; it is important for explaining its potential side effects 
(Barcellos, Lasmar, & Lasmar, 2016). 
Stage I or minimal endometriosis: Few isolated endometrial implants outside the 
uterus; there is minimal number of mild adhesions in one area, if any (Mashayekhi et al., 
2017). 
Stage II or mild endometriosis: Few isolated, slightly deeper endometrial implants 
outside the uterus; there is minimal number of mild adhesions in one area (Mashayekhi et 
al., 2017) 
Assumptions 
There were several assumptions that were assumed in this study. First, it was 
assumed that the diagnostic laparoscopic procedures performed on each of the women 
whose charts were assessed for this study were well performed and preceded by 
appropriate preoperative assessment. For example, it was assumed that each of the 
women’s diagnostic laparoscopic procedures were followed by biopsies in order to obtain 
histological confirmation of the diagnosis. Second, it was assumed that all women whose 
charts were assessed for this study underwent laparoscopic procedure strictly for the 
reason to either confirm or deny the presence of endometriosis. Third, it was assumed 
that all women whose charts were assessed for this study did not seek any type of fertility 
treatment (e.g., fertility drugs, in vitro fertilization (IVF), intrauterine insemination (IUI), 
etc.) aside from the removal of endometriosis via laparoscopic procedure. The fourth and 
final assumption was that all women whose charts were assessed for this study wished to 
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conceive. Such assumptions were necessary in the context of the study given that poorly 
performed laparoscopic procedures not followed by biopsies can be less informative and 
of limited value (Dunselman et al., 2014). Furthermore, if women chose to undergo 
laparoscopic procedure for other reasons, such as having a history of pelvic infection, 
conclusions to be made from study results given the variables could be flawed. Last, if 
any of the women whose charts were assessed underwent any type of fertility treatment 
aside from the removal of endometriosis via laparoscopic procedure, bias could be 
introduced to the study results. 
Scope and Delimitations 
The delimitations of this study were age and being a patient at any OB-
GYN/fertility clinic located in Eastern North Carolina. Given the geographical scope of 
the study, it is possible that the data were not representative of women living in other 
parts of North Carolina, and it also was possible that the data were not representative of 
other age groups outside from the ones assessed in this study (i.e., age 18-35). This study 
included data from medical charts of women of all races/ethnicities who were considered 
to be of reproductive age. Given that not just one particular race/ethnicity was 
considered, the study results do not favor one race/ethnicity over another. In order to 
meet the inclusion criteria, patients had to be in the age range of 18-35 years, as such age 
group is considered to be within good standards in regard to reproduction, with women’s 
fertility decreasing substantially by their late 30s (Lezzoni et al., 2014). Furthermore, 
only patients diagnosed with Stage I (or minimal) or Stage II (or mild) were 
endometriosis used for this study. I did not include data on women who were over the age 
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of 35, as I wanted to avoid the factor of age as a possibility for infertility, alone. Also, I 
did not include data on women who possessed multiple locations of deep adhesions or 
implants (i.e., implants/adhesions involving multiple organs), as I wanted to accurately 
compare how site/location of endometrioma might affect the association between 
infertility and the age in which a woman is diagnosed with endometriosis separately. 
The scope of this study was aided by the Andersen model, as this model has been 
used for a variety of disorders to explain aspects regarding delay stages of disease (e.g., 
appraisal, illness, behavioral, scheduling, and treatment; Walter et al., 2012). I used the 
Andersen model to determine whether diagnosis of endometriosis potentially poses a 
higher incidence for risk (i.e., infertility) based on age. The model also aided in furthering 
an explanation of why certain time intervals exist between onset of symptoms of 
endometriosis and formal diagnosis. The feminist standpoint theory (FST) also was 
considered for this study, but was found to be inappropriate given that many of its claims 
are argued by researchers and also given that its fundamental structure focuses on 
epistemologies of ignorance among male physicians towards female patients (Reid-
Hresko & Goldman, 2016), which would not guide the research questions for this study.  
I decided to study existing medical charts of women who were considered to be of 
good reproductive age (e.g. age 18-35 years) because women of such age groups are 
expected to be able to successfully conceive, especially without any given reproductive 
disease (Reid-Hresko & Goldman, 2016). I decided not to exclude the assessment of 
patients’ medical charts based on certain races/ethnicities because I did not wish to 
consider any potential racial disparities in regard to endometriosis given that similar rates 
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of the disease are observed among women of different races (Gerlinger, Faustmann, 
Hassall, & Seitz, 2012). 
Limitations 
This study contained several limitations. The first limitation was the I only used a 
secondary analysis of existing data. The data were not originally collected in order to 
address the particular research question or to test the particular research hypotheses, 
which is a limitation to a study (Cheng & Phillips, 2014). Another limitation included the 
conducting of a secondary analysis of existing data, as I was not involved in the data 
collection process; therefore, I was unaware of any nuances in the data collection process 
that might be important to the interpretation of the key variables (Cheng & Phillips, 
2014). A third limitation related to race/ethnicity. I did not assess race or ethnicity among 
women whose medical charts were assessed. The association between the age in which a 
woman is diagnosed with endometriosis and infertility might differ when the factor of 
race is considered; even though endometriosis rates are considered to be similar among 
races (Gerlinger et al., 2012). A fourth limitation related to the marital status of women. I 
did not take into consideration the marital status of the women whose medical charts 
were assessed. Such sociodemographic variable could influence fertility status given that 
married couples are considered to be more likely to try to conceive than unmarried 
couples (Laplante & Fostik, 2015). 
Significance 
Although suppressive medical treatment for endometriosis does not improve 
fertility, the age of a woman when diagnosed with endometriosis has not been taken into 
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consideration (American Society for Reproductive Medicine, 2012) prior to this study. 
Diagnosis at an earlier age can serve as a preventative strategy against infertility. 
Therefore, the purpose of this study was to determine if there was a statistically 
significant association between the age of a woman when diagnosed with the disease and 
infertility. The relationship between the two is not understood (Dunselman et al., 2014). 
Because there are no studies on the potential association between the age of women when 
diagnosed with the disease and infertility, the outcomes from the study might aid in the 
development of better precautionary methods for avoiding infertility while living with 
endometriosis. 
The findings of the study are expected to provide information on theories about 
the disease that perhaps are false/misleading, as well as serve as an asset for supplying 
readers with knowledge regarding the topic; which ultimately should better help 
individuals recognize and understand “normal” menstrual cycles versus abnormal 
menstrual cycles, as well as “normal” symptoms associated with menstrual cycles versus 
serious abnormal pain that can be linked to endometriosis. Again, the study also is 
expected to serve as evidence for why confirming endometriosis diagnoses carefully and 
more promptly should be of higher concern to physicians.  Furthermore, in regard to 
social change, the study hopefully will be able to provide a sense of support for women 
who suffer from the disease, inspiring them not to overlook health emergencies out of 
fear or frustration that there is no hope and/or relief exists.  Women should be made 
aware that effective treatment is available if they seek it.  All in all, the study is expected 
to promote social change by further supporting the devastating effects of endometriosis 
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that burden women and their families since the disease currently is not recognized as a 
medical disability (Jones, 2016).  
Summary 
Although endometriosis has been well-documented in medical texts for more than 
4,000 years and was formally discovered microscopically by von Rokitansky in 1860 
(Nezhat, Nezhat, & Nezhat, 2012), the disease still remains the subject of debate, 
especially over the last decade (Brosens & Benagiano, 2011). Furthermore, although 
laparoscopic procedure was introduced in the early 1960s, which can be used to 
distinguish between three different clinical presentations of endometriosis (i.e., 
peritoneal, deep adenomyotic, and cystic ovarian; Brosens & Benagiano, 2011), diagnosis 
of endometriosis is delayed anywhere from 7-10 years and is poorly recognized by 
physicians in practice, often leading to misdiagnosis and/or suboptimal care (Johnston et 
al., 2015). 
In this chapter, the background of endometriosis was explained, along with its 
association to infertility. Introduction to the research literature regarding the topic was 
provided. The purpose of the study was established. In addition, the research questions 
and hypotheses, the nature of the study, important terms/definitions, assumptions, scope 
and delimitations, limitations, and significance of the study were discussed. 
In Chapter 2, a detailed review of the literature is provided. In Chapter 2, I 
summarize a range of topics related to endometriosis: endometriosis as a disease, the 
impact of endometriosis on women’s lives, the different sites/locations endometriosis can 
occur, treatment for endometriosis, the association between endometriosis and infertility, 
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and the presence of uterine fibroids among patients diagnosed with endometriosis. The 
theoretical framework is further discussed as well, along with implications for the use of 
a secondary data analysis in the form of patients’ medical records.  
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Chapter 2: Literature Review 
Introduction 
Considered to be the primary cause of infertility in the United States, with a 
prevalence of 0.5%-5% in fertile women and 25%-40% in infertile women, endometriosis 
diagnosis is delayed among women anywhere from 7-10 years and is poorly recognized 
by physicians in practice (Juneau Biosciences, 2016; Johnston et al., 2015). 
Endometriosis often is misdiagnosed and many women receive suboptimal care (Johnston 
et al., 2015). The optimal choice of management for endometriosis-associated infertility 
is unknown (Dunselman et al., 2014). Although infertility and endometriosis are 
connected, the association between endometriosis and infertility still remains uncertain 
(American Society for Reproductive Medicine, 2012). The longer endometriosis goes 
undiagnosed, the more damaging it can be to women’s bodies; physicians often times 
misdiagnose common symptoms linked to endometriosis (Levett, 2016). For example, 
many patients claim to have a long history of doctor visits due to lower abdominal and 
pelvic pain only to receive no support from physicians aside from receiving a prescription 
for painkillers (Johnston et al., 2015).  
 Because the causes of female infertility is receiving less attention in the literature 
(Bell, 2014), the purpose of this study was to determine whether there was an association 
between the time in which a woman is diagnosed with endometriosis (i.e., age of woman 
when diagnosed) and infertility. The results of this study can may lead to improved 
understanding of the association between endometriosis and infertility, specifically in 
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regards to how the age in which a woman is diagnosed with the disease might affect her 
ability to conceive.  
 Because endometriosis is an estrogen-dependent condition characterized by 
endometrial glands and stroma located outside the uterine cavity (Bruggmann et al., 
2016), sites where endometriosis can implant will be discussed. Furthermore, I will 
discuss how endometriosis can affect not only the woman suffering from the disease, but 
also those around her, such as a partner or spouse (Moradi et al., 2014). Although there is 
no cure for endometriosis (Endometriosis Association, 2016), treatment options available 
for women who suffer from the disease will be discussed. I will examine how 
endometriosis is considered to be the primary cause of infertility in the United States, and 
I will discuss the association between endometriosis and infertility. Last, I will explore 
how presence of uterine fibroids in women with endometriosis. 
Literature Search Strategy 
The literature was searched using the following databases: MEDLINE, CINAHL, 
EBSCO, PubMed, and Science Direct. Keywords used to search the literature included 
endometriosis, endometriosis AND quality of life, endometriosis AND work productivity, 
endometriosis location, implantation of endometriosis, laparoscopy, laparoscopic 
procedure for endometriosis, endometriosis AND infertility, infertility, endometriosis 
AND reproductive function, reproductive function, endometriosis AND uterine fibroids, 
uterine fibroids, the general model of total patient delay, and the Andersen model. 
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Theoretical Foundation 
Various theoretical foundations have been used by researchers to study the delay 
in diagnosis of endometriosis. Chilet-Rosell (2014) used the FST to study why 
recognition of health problems specific to women (e.g., endometriosis and endometrial 
cancer) have been slow over the years. According to the FST, women’s knowledge often 
is excluded from the construction of ideology, and traditional science ignores and 
marginalizes women’s way of thinking (Borland, 2016). Chilet-Rosell suggested that 
there is gender bias in knowledge dissemination, often leading to the hindrance of the 
discovery of diseases that impact women. Similarly, various theoretical foundations have 
been used by researchers to study the link between endometriosis and infertility. 
Galhardo, Moura-Ramos, Cunha, and Pinto-Gouveia (2015) used the social cognitive 
theory and suggested that women who suffer from endometriosis and who are also 
considered to be infertile present a perception of failure and defeat and also feel that there 
is no solution to their infertility; women who do not suffer from endometriosis but also 
are considered to be infertile do not feel the same perception of failure and defeat, nor the 
feeling that there is no solution to their infertility.  
Reducing diagnostic delays may result in improved prognosis for most disorders 
(Walter et al., 2012). The general model of total patient delay, also known as the 
Andersen model, can be used to explain delay in the stages of disease (e.g., appraisal, 
illness, behavioral, scheduling, and treatment; Walter et al., 2012). The initial Andersen 
model was used to predict and explain the use of health services, but was later revised to 
include systematic concepts of health care (e.g., current policy, resources, and 
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organization; Andersen & Newman, 1973). The second-generation model, however, 
extended into outcomes of interest beyond use to consumer satisfaction (Andersen & 
Newman, 1973). Eventually, the model began to include personal health practices as an 
antecedent to outcomes, which involved the acknowledgement of health services and 
satisfaction of health services among patients (Andersen & Newman, 1973). The latest 
iteration of the Andersen model turns to individuals as the unit of analysis, going beyond 
health care use and adopting health outcomes as the endpoint of interest (Andersen & 
Newman, 1973). Different from similar theories, the Anderson model includes a feedback 
loop to illustrate that health outcomes may affect aspects of health beliefs and need 
(Andersen & Newman, 1973). 
The Andersen model was used in this study as a means to support whether 
diagnosis of endometriosis might pose a higher incidence for risk (i.e., infertility) based 
on age. The model also aided in explaining of why certain time intervals exist between 
onset of symptoms of endometriosis and formal diagnosis given that the model. 
According to the Anderson model, diagnostic delay results from conceptual beliefs about 
a person’s symptoms; behavioral factors, such as strategies for self-appraisal; and 
techniques for coping with illness and emotional reaction (Walter et al., 2012). Evans, 
Ziebland, and McPherson (2007) used the Andersen model to account for diagnostic 
delays in a sample of British women with ovarian cancer. Evans et al. conducted 
semistructured interviews with 43 women (ages 33-80 years; mean age: 54 years), 
determining that most of the women (38 of 43 participants) reported prediagnostic 
symptoms and diagnostic delays. The recording of patient delays conformed to 
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Andersen’s first four types of delays: appraisal, illness, behavioral, and scheduling. 
Furthermore, treatment delays, as drawn from Anderson’s model, included 
noninvestigation of symptoms, treatment for noncancer causes, lack of follow-up, referral 
days, and system delays (Evans et al., 2007). By using the Andersen model as an analytic 
framework for the study, Evans et al. concluded why some British women experience 
delays in obtaining ovarian cancer diagnosis. Furthermore, Evans et al. used the 
analytical framework to explain how diagnostic delays for ovarian cancer could be 
minimized. 
In a correlational, quantitative study, Ozturk, Fleer, Hoekstra, Josetta, & 
Hoekstra-Weebers (2015) used Andersen’s model of total patient delay to explain how 
delay in diagnosis of testicular cancer (TC) could pose higher incidence for risk for 
decreased survival. Ozturk et al. used a questionnaire to gain insight from 60 men (ages 
17-45 years; median age: 26 years) who were diagnosed with TC at a university medical 
hospital in the Netherlands. Using the Andersen model, Ozturk et al. concluded that the 
median patient delay of 30 days (range 1-365 days) was due mostly to lower educated 
men and men embarrassed about their scrotal change (r=-.25, r=.79, respectively. 
Furthermore, Ozturk et al. used the model to support the conclusion that age, marital 
status, TC awareness, warning signals, and perceived limitations were not associated with 
patient delay. Ozturk et al. used the model to conclude that the most important risk 
variable in general practitioners was misdiagnosis and that TC awareness programs could 
decrease misdiagnoses and delays in diagnoses in order to improve disease survival. 
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Literature Review Related to Key Variables and/or Concepts 
Endometriosis 
Endometriosis is the presence of endometrial-like tissue outside the uterus, and it 
is a chronic disease associated with pelvic pain and subfertility (Nnoaham et al., 2011). 
Endometriosis is most commonly known to affect the ovaries, fallopian tubes, and the 
tissue lining the pelvis; although in rare cases, endometrial tissue has been found to 
spread beyond the pelvic organs (Mayo Clinic, 2016). In the case that endometriosis 
occurs, endometrial tissue that is displaced continues to act as it normally would by 
thickening and breaking down and bleeding with each menstrual cycle (Mayo Clinic, 
2016). However, because the displaced tissue is prohibited from exiting the body, it 
becomes trapped and surrounds tissue, causing the tissue to become irritated, which 
causes the development of scar tissue and adhesions, further leading to the fusion of 
certain organs (Mayo Clinic, 2016).   
Laparoscopy is a procedure used to diagnose endometriosis by inserting a lighted 
viewing instrument (i.e., laparoscope) through a small incision; this is the most common 
technique for removing mild to moderate endometriosis (WebMD, 2016). Laparoscopic 
procedure works by viewing the internal organs to look for signs of endometriosis and by 
removing visible endometriosis implants and scar tissue that causes pain or leads to 
infertility (WebMD, 2016). Because a definitive diagnosis is established only at 
laparoscopy, prevalence rates of endometriosis in the general population remains obscure 
(Nnoaham et al., 2011). Based on community prevalence of symptoms, however, it is 
estimated that endometriosis affects 10% of all women and 30%-50% of symptomatic 
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premenopausal women (i.e., ~176 million women affected worldwide; Nnoaham et al., 
2011). Furthermore, the prevalence of endometriosis among fertile women is 0.5%-5%, 
and the prevalence of endometriosis among infertile women is 25%-40% (Juneau 
Biosciences, 2016). 
Endometriosis Implantation/Location 
 Because endometriosis is an estrogen-dependent condition characterized by 
endometrial glands and stroma outside the uterine cavity, implantations are found in the 
peritoneum, the ovaries, and the rectovaginal septum, which constitute three different 
disease entities (Burggmanet al., 2016). Via laparoscopic procedure, disease location and 
phenotype (i.e., superficial, deep infiltrating, endometriomata) can be determined 
(Menakaya, Lu, Infante, Lam, & Condous, 2014). 
 Menakaya et al. (2014) examined 104 women living with endometriosis. 
Menakaya et al. found that the most common phenotype of endometriosis among the 
women was superficial endometriosis, with sites of endometriosis located in the pelvic 
area, on and below the ovaries, and deep in the pelvis area behind the uterus. The most 
common diagnoses made among the sample of women via diagnostic laparoscopy for 
pelvic pain consisted of pelvic endometriosis and adhesions (Menakaya et al., 2014). The 
list of endometriosis implantations/locations among the women included the uterus, 
ovaries, fallopian tubes, pouch of Douglas (POD), uterovesical fold, uterosacral 
ligaments, rectovaginal space, left and right pelvic side walls (i.e., from pelvic brim to 
ureteric tunnel), and peritoneal surfaces throughout the pelvis and upper abdomen 
(Menakaya et al., 2014). Given all of the examined implantations/locations of 
23 
 
endometriosis among the women, only 24/100 (23%) had a history of infertility, with 
only 3/104 (2.9%) having undergone hysterectomy (Menakaya et al., 2014). There was 
no correlation between the site of pain and location of the disease (Menakaya et al., 
2014). 
Although the most common reason leading up to laparoscopic surgery–often 
ending in diagnosis of endometriosis–is pelvic pain, variation in the sites of 
endometriosis and how those sites may or may not affect chances of infertility are lacking 
(Maggiore et al., 2016). Pereira and Kilgman (2016) found that a 31-year-old woman 
presented to a clinic who had a 2-year history of infertility, when finally having 
undergone laparoscopic surgery, was determined to have endometriosis on her right 
fallopian tube. Whether the woman’s infertility was due to endometriosis or primary 
infertility was, however, undetermined (Pereira & Kilgman, 2016). Consideration 
regarding site/location in which endometriosis exists within a woman’s body might be 
helpful in regards to assessing the potential association between age of women when 
diagnosed with endometriosis and infertility, especially given that several variations in 
fallopian tube anatomy are notable during the evaluation of infertility because disease 
affecting the fallopian tubes account for nearly 25%-35% of all infertility cases (Pereira 
& Kilgman, 2016). 
Impact of Endometriosis on Women’s Lives 
The prevalence of endometriosis among women with pelvic pain is 20%-90%, 
although the etiology and pathogenesis is not known (Moradi et al., 2014). Often labeled 
as the missed disease, the average time between the onset of pain and diagnosis is nearly 
24 
 
8 years in the United Kingdom and nearly 12 years in the United States (Moradi et al., 
2014). The quality of life for many patients with endometriosis is negatively affected, and 
some women experience the emotional impact of subfertility, anger about disease 
recurrence, and uncertainty about the future in regard to repeated operations and/or long-
term medical therapy (Moradi et al., 2014). Moradi et al. (2014) identified impaired 
health related to quality of life and work productivity across countries and ethnicities, 
further concluding that women continue to experience a delay in diagnosis. From a 
sample of 35 women who were formally confirmed to have endometriosis via 
laparoscopy diagnosis and who were purposely recruited in order to avoid potential bias, 
Moradi et al. determined that most participants experienced pain, dyspareunia, 
heavy/irregular bleeding, and infertility, and all suffered from severe and progressive 
pain in areas such as the lower abdomen, bowel, bladder, lower back and legs during both 
menstrual and nonmenstrual phases. Other symptoms reported to negatively impact the 
women’s lives included fatigue, tiredness, bloating, bladder urgency, bowel symptoms 
(e.g. diarrhea), bladder symptoms, and sleep disturbances due to intense pain (Moradi et 
al., 2014).  
Among the three age groups included in Moradi et al.’s (2014) study (e.g., 16-24 
years; 25-34 years; >35 years), Moradi et al. also showed that the most detrimental 
impact of endometriosis on the women’s lives stemmed from negative effects on 
marital/sexual relationships, social life, and physical and psychological wellbeing. Most 
of the participants were either married or had a partner and had a history of living with 
endometriosis anywhere from 2 to 40 years (Moradi et al., 2014). The mean age in which 
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endometriosis-related symptoms were first experienced were reported by the participants 
to be 17.4 ± 6.8 years (range: 11-41), with diagnosis made at 25.6 ± 7.9 years (range: 15-
42), and delay in diagnosis of endometriosis found to be 8.1 ± 6 years (range: 3 months - 
24 years; Moradi et al., 2014). Furthermore, almost half of the participants (17 out of 35) 
reported that endometriosis interfered with their life and only 54.3% of participants (19 
out of 35) reported moderate satisfaction with their treatment (Moradi et al., 2014). 
According to the American Society for Reproductive Medicine (ASRM), stages 
of endometriosis are based on both the extent and location of endometriotic adhesions, 
with minimal endometriosis (Stage I) being indicative of minimal or superficial ovarian 
and peritoneal implants and severe endometriosis (Stage IV) consisting of deep, dense 
endometriotic implants (North Shore Medical Center, 2016). There is no correlation 
between stage and symptoms of endometriosis, which may result in misdiagnosis or 
delayed diagnosis of endometriosis (Gao, Yeh, Outley, Simon, Botteman, & Spalding, 
2008). Because two-thirds of women with chronic pelvic pain (CPP) in the United States 
do not seek medical attention, Goa et al. (2008) evaluated the impact of endometriosis on 
the lives of the particular population. Goa et al. used the conceptual model developed by 
Wilson and Cleary, which states that biological and physiological variables may lead to 
physical and psychophysical symptoms that affect a person’s functioning, general health 
perception, and overall health related quality of life (HRQL).   
Goa et al. (2008) examined studies that measured the HRQL impact of 
endometriosis and its key symptoms; analyzed the impact of pharmacological and 
surgical treatments of endometriosis on HRQL; and reviewed the literature pertaining to 
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the presence and impact of endometriosis in adolescents, who are considered to be an 
overlooked patient population. Goa et al. found five dimensions of health status were 
addressed, which consisted of mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression. Each of the five dimensions were divided into three levels: no 
problem, some problem, or extreme problem (Goa et al., 2008). Goa et al. determined 
that compared with a group of women not diagnosed with endometriosis, there were 
unfavorable results among the endometriosis group in regards to inference with daily 
activities, health distress, and pain during or after intercourse (p < 0.05 for all). 
Furthermore, among those suffering from endometriosis, there were higher reports of 
anxiety-depression, sleeplessness, irritability, dyspareunia, painful defecation, dysuria, 
dysmenorrhea, and overall discomfort on the visual analogue scale (VAS; Goa et al., 
2008). According to Goa et al., although it is known that endometriosis impacts fertility 
and sexuality, more researchers should focus on the impacts of endometriosis on the 
ability to work, the ability to play, and the ability to invest in personal relationships.  
Diagnostic delay is believed to worsen the effects of endometriosis on the 
physical, emotional, and social wellbeing of patients and their ability to work (Giuliani et 
al., 2015). Pelvic pain, which represents the clinical problem of the disease (manifesting 
as dysmenorrhea, dyspareunia, chronic pelvic pain, and less frequently, dysuria and 
dyschezia) results in adverse effects on women’s working abilities and psychosocial 
functioning (Giuliani et al., 2015). General quality of life (QoL) and sexual satisfaction 
are compromised in women with endometriosis (Giuliani et al., 2015).  I stopped 
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reviewing here due to time constraints. Please go through the rest of your chapter and 
look for the patterns I pointed out to you. I will now look at Chapter 3. 
An experimental study by Giuliani et al. (2015) aimed to evaluate QoL and sexual 
satisfaction in a group of Italian women affected by endometriosis while identifying 
specific sociodemographic variables that could impact the individual perception of the 
disease. A survey was conducted on 150 women with endometriosis who were recruited 
at a University hospital in Rome in the department of gynecology for service of 
endometriosis and pelvic pain (Giuliani et al., 2015). The control group included 150 
women who were considered to be healthy (e.g. not diagnosed with endometriosis) and 
who were matched for age and relationship status. Age of participants ranged from 22-50 
years (mean age=35.75; SD=6.90) (Giuliani et al., 2015). Sociodemographic 
questionnaires (i.e. the Italian version of the World Health Organization Quality of Life - 
Bref (WHOQOL-Bref), McCoy Female Sexuality Questionnaire (MFSQ), and the Visual 
Analogue Scale (VAS)) also were administered to participants. WHOQOL-Bref was used 
to assess the QoL perceived by participants in four different areas: physical, 
psychological, social relationships and environmental; and MFSQ was used to assess 
sexual and relationship satisfaction, analyzing two specific factors: sexuality and 
partnership (Giuliani et al., 2015). The level of pain related to dysmenorrhea, chronic 
pelvic pain, and dyspareunia were evaluated through VAS (e.g. 0=no pain, from 1-
3=mild pain, from 4-7=moderate pain, from 8-10=severe pain) (Giuliani et al., 2015).   
No statistical differences between the groups in relation to the sociodemographic 
variables (e.g. educational level, marital status, employment status, etc.) were found 
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except for the presence of children, with 86.7% of women in the experimental group not 
having children compared to only 58.7% of women in the control group not having 
children (Giuliani et al., 2015). Interestingly, though, data did show that the experimental 
group obtained a lower score than did the control group in the questionnaire total scores 
in terms of the sexual satisfaction domain (P<0.01) (MFSQ) and the physical, 
psychological and social relationships domains (P=0.00) (WHOQOL-Bref) (Giuliani et 
al., 2015).   
Results from the experimental study suggest that clinical symptoms presented by 
endometriosis such as pain, tissue fibrosis, chronic inflammatory status, and the presence 
of neuroactive agents can severely affect sexual life (Giuliani et al., 2015). For example, 
women with endometriosis were found to be much less satisfied with their QoL in 
general, as well as in physical health, psychological and social relations domains when 
compared with women without endometriosis (Giuliani et al., 2015). Furthermore, 
women with endometriosis were found to have less sexual satisfaction than women 
without endometriosis (Giuliani et al., 2015). Given the higher percentage of women 
without children in the experimental group (86.7%) versus the percentage of women 
without children in the control group (58.7%), it is possible that many women without 
children in the experimental group faced problems of infertility – which actually was not 
explored in the aforementioned study. Given that there is a reason to believe that health-
related quality of life is greater among parents than non-parents in regards to emotional 
support (Eiser & Varni, 2013), perhaps the quality of life of women with endometriosis in 
the study would have been greater if problems related to infertility were non-existent. 
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With that being said, assessing an impactful association between time in diagnosis of the 
disease and infertility in women might yield answers that provide a better quality of life 
for women who suffer from the disease by allowing them to conceive. In order determine 
such impactful association, though, formal diagnosis must first take place before 
appropriate options for treatment can be made available (Endometriosis Association, 
2016). 
Treatment 
From patients’ point-of-view, endometriosis is a nightmare of misfortune, myths, 
lack of diagnosis, and problematic “hit-and-miss” treatments, all of which are overlaid by 
the painful, chronic, stubborn disease (Moradi et al., 2014). Although there is no cure for 
endometriosis, there are a variety of treatment options that aim to relieve/reduce pain 
symptoms, shrink or slow down endometrial growths, preserve or restore fertility, and 
prevent and/or delay recurrence of the disease (Endometriosis Association, 2016). Such 
treatment options include: pain medication in the form of over-the-counter pain relievers, 
for instance aspirin and acetaminophen, as well as prostaglandin inhibitors like ibuprofen, 
naproxen sodium, indomethacin, tolfenamic acid, and in some cases the requirement of 
prescription drugs; pain relief such as ProSirona, which is a new product that targets 
endometriosis and is applied topically on the area of pain with the main ingredients being 
essential oils combined in a technologically advanced way; hormonal therapy aimed to 
stop ovulation for as long as possible, such as oral contraceptives, progesterone drugs, 
testosterone derivatives (e.g. danazol), and GnRH agonists (gonadotropin releasing 
hormone drug); surgery, which seeks to remove and destroy endometrial growths, relieve 
30 
 
pain, and increase the chances of pregnancy; and last, alternative treatments such as 
traditional Chinese medicine, nutritional approaches, homeopathy, allergy treatment, and 
immune therapy (Endometriosis Association, 2016).  
When it comes to perceptions of endometriosis-related treatment, overall, the 
ideal outcome of surgical intervention in patients suffering from endometriosis-related 
infertility is for the anatomical relationship to be restored and for the function of the 
pelvic organs to be preserved (Gizzo et al., 2014). An observational cohort study by 
Gizzo et al. (2014) compared two large cohorts (Group A and Group B) of infertile 
women affected by endometriosis who underwent laparoscopic treatment strictly for the 
purpose of restoring/improving their fertility by either a skilled surgeon (Group A) or a 
surgeon strictly dedicated to endometriosis-related infertility (Group B). Comparisons 
among the two groups were made in regards to perioperative surgical outcomes, 
clinical/ongoing pregnancy and live birth rates, spontaneous pregnancy rate, and 
obstetrical outcome (Gizzo et al., 2014). Participants included in the study consisted of 
women aged 18-42 years, who had a preoperative suspicion of endometriosis confirmed 
by histology, who had a history of infertility, and who had a desire of pregnancy (Gizzo 
et al., 2014). Furthermore, participants were required to be of Caucasian ethnicity, have 
no history of previous concomitant malignant disease, no severely impaired ovarian 
reserve, and no systemic diseases which potentially could interfere with fertility (e.g. 
diabetes and disthyroidism) (Gizzo et al., 2014).  
After it was determined that there was a significantly higher spontaneous fertility 
rate (particularly in the first year after surgery) and lower ectopic pregnancy rate in 
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Group B post surgery, Gizzo et al. (2014) concluded that in patients affected by 
endometriosis, the choice should be personalized in regards to deciding between 
expectant management versus intervention. For example, in the case that estimated 
probability of natural conception is low, surgery may need to be considered as a second-
line treatment. However, in all other cases, surgery should be offered early (i.e. as a first-
line approach) as it can improve the chance of spontaneous conception (Gizzo et al., 
2014). 
Due to difficulty in long-term management of endometriosis symptoms and 
unpredictability of treatment outcomes, treatment options such as herbal medicine stand 
necessary in endometriosis research (Stephens, Whitehouse, & Polley, 2013). With that 
being said, a study by Stephens, Whitehouse, & Polley (2013) reviewed commonly used 
herbs in the treatment of endometriosis, the effects of phytochemical constituents on 
endometrial cells, and the impact such treatment had on the epigenome. Stephens et al. 
(2013) defined treatment of endometriosis as reduction of pain and prevention of pain 
recurrence. Long history of documented evidence regarding herbal medicine for 
endometriosis-like symptoms has led to an increase in popularity of herbal medicine, 
specifically in the West, for treating endometriosis in attempt to overcome poor long-
term success at resolving chronic pain or recurrence of the disease using conventional 
intervention (Stephens et al., 2013). Recent data on dienogest (a 19-nortestosterone 
derivative) for pain management in endometriosis presented by the Royal College of 
Obstetricians and Gynecologists (RCOG) actually reports, for example, that women with 
endometriosis prefer complementary medicine (e.g. herbal medicine) over nonsteroidal 
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anti-inflammatory drugs (NSAIDs) and analgesics (Stephens et al., 2013). Such increase 
in preference regarding herbal treatment was found to be attributed to known effects on 
the signaling pathways associated with pathogenesis of endometriosis, further 
demonstrating anti-proliferative, antioxidant, analgesic, and inflammatory effects on 
endometrial cells (Stephens et al., 2013).  
Unfortunately, standard medication and surgical treatments of endometriosis 
show high recurrence of symptoms (Prather, MacLean II, Shi, Boadu, Paquet, & Hayashi, 
2016). Due to such high rates of recurrence, it is suggested that current treatment options 
be improved (Prather et al., 2016). Long-term treatment of patients who experience 
chronic pelvic pain associated with endometriosis often involves repeated courses of 
therapy, whether surgical, medical or both (Prather et al., 2016). Laparoscopic surgery, 
for example, is found to provide relief of symptoms from the disease, only to have an 
estimated 50% recurrence rate after five years (Prather et al., 2016). Furthermore, GnRH 
agonist therapy is estimated to have a 50% or even higher rate of recurrence of symptoms 
over time (Prather et al., 2016). With that being said, it is suggested that therapeutic 
targets and efficient drugs that potentially could be improvements over current treatment 
options be identified (Prather et al., 2016). 
In an experimental study by Prather et al. (2016), it was examined whether the 
non-steroidal drug niclosamide could be a useful drug for endometriosis in a preclinical 
setting. Niclosamide is defined as an efficacious, minimally toxic and FDA-approved 
anti-helminth drug that has been used in patients for decades (Prather et al., 2016). 
Niclosamide is reported to aid in the disruption of multiple signaling pathways including 
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NFĸB, STAT3, and WNT signaling in a variety of cancer models (Kim et al., 2013).  
Given the history of the drug in cancer models, it was hypothesized that the drug could be 
an inhibitor of endometriosis progression by blocking signaling pathways (Prather et al., 
2016). For the experimental study, endometriotic implants were surgically inserted into 
donor mice who were currently experiencing the diestrus stage of the reproductive cycle 
(Prather et al., 2016). After 3 days of recovery, recipient mice received niclosamide 
orally at a dose of 0 (n=8), 100 (n=5), or 200 (n=10) mg/kg b.w./per day for 3 weeks. 
More than 95% of mice ate their completed dosage of niclosamide within 30 minutes 
(which was mixed in gelatin with artificial flavors for taste). After the 3 weeks of 
treatment, the recipient mice were necropsied, and the endometriotic implants were 
distinguished under a Fluorescence Stereo Microscope and collected for further analysis 
(Prather et al., 2016). Further analysis included determining whether there was an effect 
of niclosamide treatment on reproductive functions, where mice then were randomly 
assigned for control (n=11) or niclosamide (n=7) group.   
A significant difference in the pattern of growth of the endometriotic implants 
were discovered, with niclosamide treated mice at a dose of 100 mg/kg b.w./per day 
having showed a significant reduction of implant weight (0.023 ± 0.004 g) and growth 
(4.63 ± 1.00 fold from initial implant size) compared to controls (implant weight: 0.044 ± 
0.007 g, and growth: 8.66 ± 1.10 fold) (Prather et al., 2016). Furthermore, niclosamide 
treated mice at a dose of 200 mg/kg b.w./day also presented a reduced implant weight 
(0.016 ± 0.003 g) and growth (1.90 ± 0.40 fold) compared to controls (Prather et al., 
2016). Importantly, it was found that niclosamide had no effect on reproductive function, 
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as all mice exposed to niclosamide became pregnant and gave birth (Prather et al., 2016). 
Also, there were no alterations in regard to gestational length, number of pups, and 
weight of pups at birth upon the mice being exposed to niclosamide (Prather et al., 2016).  
Such results from the experimental study indicate that treatment (i.e. niclosamide) 
can be effective for endometriosis, acting as an inhibitor of inflammatory signaling 
without disrupting normal reproductive functioning (Prather et al., 2016). As an 
important contribution to the present study, though, Prather et al. (2016) presented the 
importance regarding the stage in which the female mice were treated. For example, 
specifically given the fact that the recipient mice were strictly selected to receive 
treatment in the case that they were undergoing the diestrus stage, which is equivalent to 
the estrus stage in humans, classifying women as being at the most effective reproductive 
stage in their life (Kim et al., 2016), a 100% success rate in regards to reproduction from 
the mice post treatment provides support as to how effective treatment for endometriosis 
can be in regards to fertility if presented at an appropriate time. 
Association Between Endometriosis and Infertility 
Infertility typically is defined as the inability of couples to become pregnant after 
12 months of regular unprotected sexual intercourse (Thoma et al., 2013). Endometriosis 
is considered to be the number one cause of infertility in the United States, having a 
prevalence of 0.5%-5% in fertile women and 25%-40% in infertile women (Juneau 
Biosciences, 2016). With that being said, in vitro fertilization (IVF) is represented as the 
most successful means of achieving conception in endometriosis patients struggling with 
infertility (Surrey, 2015). Interestingly, Surrey (2015) explored the impact of 
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endometriosis on IVF cycle outcomes as well as whether surgical or medical 
management of endometriosis could impact success rates. Conclusions formulated by the 
review study suggested that women with endometriosis have similar cycle outcomes to 
other patients going through IVF who do not suffer from endometriosis although several 
earlier studies such as Barnhart et al. (2002) and Barcelos et al. (2009) suggested poorer 
outcomes associated with IVF from women suffering from endometriosis in comparison 
to controls (Surrey, 2015). The conclusion of the study, which suggested that women 
with endometriosis have similar success rates to other patients going through IVF could 
be flawed, however, given the fact that the study did not control for other infertility 
variables that could have affected the outcome (Surrey, 2015). Importantly, discrepancy 
between Surrey (2015) and earlier studies was assumed to be attributed to the decreasing 
role of laparoscopy as a means to diagnose endometriosis in order to further explore 
potential infertility issues. For example, some patients in the study who potentially could 
have been suffering from endometriosis but who had never undergone laparoscopy were 
classified with the diagnosis of “unexplained infertility” (Surrey, 2015).  
Although diagnosed in asymptomatic patients, endometriosis usually is diagnosed 
when patients present with pain and/or claims of infertility (Burghaus et al., 2016). With 
that being said, endometriosis actually is diagnosed during laparoscopy in a quarter of 
patients with infertility (Burghaus et al., 2016). Although various etiologies have been 
discussed and proposed, such as potential causes of infertility due to endometriosis being 
linked to anatomical changes of the adnexa, the association between endometriosis and 
infertility still remains unclear (Burghaus et al., 2016). Other etiologies, though, include 
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changes to the immunological milieu for implantation affecting sperm motility, as well as 
uterotubal transport disorders, and disorders of oocyte maturation (Burghaus et al., 2016). 
Although published pregnancy rates for patients with endometriosis range from 24%-
54%, such estimated rates are thought to be an overestimation given that some patients 
may not have attempted spontaneous pregnancy prior to surgery for endometriosis 
(Burghaus et al., 2016).  
Endometriosis is considered to be one of the most challenging clinical entities for 
gynecologists given the extreme difficulty linked to managing pain and infertility 
(McKenzie, 2015). With that being said, a study by McKenzie (2015) assessed a case 
study regarding the effects of endometriosis on infertility and suggests that “less is more” 
in regard to surgical management for endometriosis-associated infertility. The study 
assessed a case concerning a 34-year-old patient who presented a complaint to her 
physician in 2014 regarding infertility after attempting pregnancy for two years. 
However, the patient was only recently diagnosed with endometriosis via laparoscopy in 
December 2013 (McKenzie, 2015). Interestingly, before the diagnosis of endometriosis, 
prior fertility testing via ultrasound on the patient determined an occluded left Fallopian 
tube and an anti-Mullerian hormone (AMH) level of 1.6 ng per mL (McKenzie, 2015). 
Furthermore, via transvaginal ultrasound, bilateral endometriomas measuring 
approximately 5 and 10 cm were suspected (McKenzie, 2015). Fertility management (i.e. 
IVF) was immediately discussed versus the option of removing the endometriomas. Six 
months after the discovery of the suspected endometriomas, the patient decided to 
undergo IVF, which turned out to be unsuccessful (McKenzie, 2015). McKenzie (2015) 
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further concluded that although incidence of endometriosis can be asymptomatic in 
women trying to become pregnant/claiming to be suffering from infertility, laparoscopic 
diagnosis of endometriosis is important in regards to battling infertility. Given that 
laparoscopy for evaluation of endometriosis-associated infertility varies dramatically 
between 9%-50%, exactly how endometriosis impacts fertility remains uncertain 
(McKenzie, 2015). With that being said, perhaps assessing the association between the 
age in which a woman is diagnosed with endometriosis and infertility could help explain 
what currently is considered to be “unexplained infertility”. 
Presence of Uterine Fibroids 
Uterine fibroids are common, benign, smooth-muscle tumors that are known to 
cause major morbidity for women of reproductive age, often requiring them to undergo 
invasive treatment (Baird et al., 2015). Although uterine fibroids are considered, by 
many, to be both a personal and public health burden, there is a lack of studies that 
attempt to periodically screen women with ultrasound in order to detect incident disease 
and/or identify risk factors (Baird et al., 2015). Interestingly, uterine fibroids develop in 
the majority of reproductive-age women and are considered to be the leading cause of 
hysterectomy in the United States (Baird et al., 2015). 
Heavily impacting women’s health and fertility, endometriosis and uterine 
fibroids are common indications for surgery (Ciarmela, Critchley, Christman, & Reis, 
2013). A better understanding of the conditions – especially together – are essential for 
the development of successful medical therapies and are of interest to many clinicians 
and clinical researchers (Ciarmela et al., 2013). Although uterine fibroids and 
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endometriosis are known to contribute to a considerable amount of pain, potentially 
leading to subfertility or infertility in women, the relationship between the two is poorly 
understood (Nezhat et al., 2016). Nezhat et al. (2016) conducted a retrospective study in 
order to assess the rate of coexistence of endometriosis in women with symptomatic 
leiomyoma (i.e. uterine fibroids). The retrospective review collected medical records of 
244 patients treated at a tertiary medical center, who were evaluated for symptoms of 
uterine fibroids. Out of the 244 patients, 208 of those underwent laparoscopic procedure, 
where 181 had concomitant diagnoses of uterine fibroids and endometriosis (Nezhat et 
al., 2016).  
The most common form of uterine fibroids amongst the participants existed as 
solid pelvic tumors, which, alone, is known to affect 20%-25% of reproductive-aged 
women (Nezhat et al., 2016). Alarmingly, out of the 20%-25% of women who suffer 
from uterine fibroids in the form of solid pelvic tumors, 50% are usually symptomatic, 
where the symptoms are considered to depend on the number, size, and location of the 
tumor (Nezhat et al., 2016). The most common symptoms associated with uterine fibroids 
include abnormal uterine bleeding, pelvic pain, and extreme pressure, and risk factors 
include increased estrogen stimulation, family history of uterine fibroids, and race 
(Nezhat et al., 2016). Uterine fibroids seldom are the sole cause of infertility, but become 
a major concern when coexisting with endometriosis (Nezhat et al., 2016). Interestingly, 
Nezhat et al. (2016) suggested that dismissal of the diagnosis of endometriosis during 
surgical intervention for uterine fibroids can result in suboptimal treatment – especially in 
patients with chronic pelvic pain, infertility, or both. All in all, Nezhat et al. (2016) found 
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that because of the significant overlap of symptoms between uterine fibroids and 
endometriosis, it often is difficult to discern which pathology is responsible for patients’ 
complaints. Nezhat et al. (2016) further concluded that because patients who have 
symptomatic uterine fibroids may be at a higher risk for endometriosis and vice versa, 
suspicion for both endometriosis and uterine fibroids should be of equal concern when 
patients undergo laparoscopic procedure.  
Despite uncertainty regarding the relationship between uterine fibroids and 
endometriosis, through advances in pathogenetic knowledge of uterine fibroids, it has 
been suggested via studies such as Tocci et al. (2008) that sites in which pathological 
thickening or abnormality of sub-endometrial tissue occur also serve as the possible sites 
of origin of submucosal and intramural fibroids (Ciavattini et al., 2013). Furthermore, 
Ciavanttini et al. (2013) mentioned that although in current time, it is not well established 
exactly how uterine fibroids might interfere with the endometrial environment and the 
sub-endometrial environment and vice versa, patients who suffer from both 
endometriosis and uterine fibroids definitely have an increased risk for infertility and/or 
miscarriage, strictly due to influences related to the association between the two 
conditions. 
Summary and Conclusions 
Endometriosis is considered to be the number one cause of infertility in the 
United States, with diagnoses of the disease found to be delayed anywhere from 7-10 
years, and the disease being poorly recognized by physicians in practice (Juneau 
Biosciences, 2016; Johnston et al., 2015). This study is significant to the research topic 
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because it might increase the understanding of the issue concerning the lack of 
knowledge that exists in regards to the association between endometriosis and infertility; 
specifically in regards to how the age in which a woman is diagnosed with the disease 
might affect her ability to conceive. 
The literature presented data on the prevalence of endometriosis, as well as the 
average years of delay that exists in regards to definitive diagnosis. The review further 
demonstrated the impact of endometriosis on women, such as pain, dyspareunia, 
heavy/irregular bleeding, and infertility, which significantly affects their daily lives 
(Moradi et al., 2014). The literature revealed patients’ point-of-view regarding treatment 
for the disease and how available treatment options are problematic in that they often are 
found to be “hit-and-miss,” even though most patients undergo treatment with the 
perception that the anatomical relationship regarding fertility can be restored and the 
function of the pelvic organs will be preserved (Moradi et al., 2014; Gizzo et al., 2014). 
A number of studies have established a connection between endometriosis and 
infertility, but no researchers have considered the association between the age in which a 
woman is diagnosed with endometriosis and infertility. This study attempted to fill the 
gap in the literature by determining if there is a statistically significant association 
between the age in which a woman is diagnosed with endometriosis and being considered 
infertile. Chapter 3 will provide an overview of the research design and methodology. 
The discussion will include the target population; sampling and sampling procedures, 
including justification for effect size, alpha level, and power level; data collection 
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procedures, including access to secondary data; threats to validity; and ethical 
procedures. 
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Chapter 3: Research Method 
Introduction 
Diagnosis of endometriosis is delayed and poorly recognized by physicians in 
practice, often leading to misdiagnosis and/or suboptimal care (Johnston et al., 2015). In 
addition, investigation concerning causes of female infertility is receiving less attention. 
An optimal approach to managing infertility requires a method associated with routine 
and timely measures (Bell, 2014). However, scholars have not explored the association 
between the age of a woman when diagnosed with endometriosis and infertility. Earlier 
diagnosis of the disease (e.g., diagnosis at an earlier age) could serve as a preventative 
strategy towards infertility. If a statistically significant association between age of women 
when diagnosed with endometriosis and infertility is determined, there could be fewer 
incidences of endometriosis-related infertility. Furthermore, determining a statistically 
significant association also could provide for more effective patient/doctor visits for 
women who suffer from common symptoms of endometriosis. 
In Chapter 3, I will explore the research design and rationale of the study, explain 
the system of methods used in order to carry out the study, introduce any factors that 
could serve as threats to the validity of the study, explain ethical procedures involved in 
the gathering of data, and include a brief introduction to Chapter 4. 
Research Design and Rationale 
Quantitative researchers focus on gathering numerical data to generalize results 
across groups of people or to explain a particular phenomenon (USC Libraries, 2016). 
Furthermore, quantitative methods are used to emphasize measurements and statistical, 
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mathematical, or numerical analyses of data through the collecting of polls, 
questionnaires, and surveys, or by manipulating preexisting statistical data using 
computational techniques (USC Libraries, 2016). The goal of a quantitative study is to 
determine the relationship between one thing (i.e., the independent variable) and another 
(i.e., the dependent variable) within a population (USC Libraries, 2016). In this 
quantitative study, I aimed to determine whether there was an association between the 
age in which a woman was diagnosed with endometriosis and infertility. The dependent 
variable in the study was infertility, and the independent variable in the study was age. 
Because I also aimed to determine how history of uterine fibroids and site/location of 
endometrioma influenced the association between age of women when diagnosed with 
endometriosis and infertility, uterine fibroids and site/location were used as covariates in 
the study. 
The research design for this study was a cross-sectional design. The cross-
sectional study design is considered to be one of the most common and well-known study 
designs (Olsen & St. George, 2004). In cross-sectional studies, either an entire population 
or a subset of a population is selected, and data from individuals within the population or 
subset population are collected to answer research questions (Olsen & St. George, 2004). 
A cross-sectional research design was appropriate for this study because data on a group 
of women diagnosed with endometriosis in Eastern North Carolina were assessed in order 
to answer the research questions.  
Epidemiologists analyze preexisting data to find answers to questions (Olsen & 
St. George, 2004). A secondary data analysis of preexisting data retrieved from medical 
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records of patients at multiple OB-GYN clinics in Eastern North Carolina was used for 
this study. Incorporating secondary data from patients’ medical records allowed me to 
search through a wider range of materials covering larger areas over longer periods of 
time in shorter duration than would have been possible using only primary data. By using 
statistical analysis, I could better understand the historical context behind patients’ 
medical struggle with endometriosis. For example, via preexisting medical records, I was 
able to assess–through physician documentation–when patients first complained of onset 
of symptoms related to endometriosis, when patients underwent laparoscopic surgery to 
definitively diagnosis endometriosis, whether or not they were considered to be suffering 
from infertility, and the age in which all series of events took place. 
These research designs are needed to advance knowledge in the social sciences 
discipline because they provide a basis for describing patterns of relation or association 
between variables (Frankfort-Nachmias & Nachmias, 2008). By using a cross-sectional 
research design, I was able to investigate the association between variables to further 
contribute to the knowledge concerning the association between endometriosis and 
infertility. 
Methodology 
Population 
The target population for this study was women living in Eastern North Carolina, 
between the ages of 18 and 35 years, who were formally diagnosed with endometriosis 
via laparoscopic surgery. The pool of eligible women whose medical records were 
assessed for this study was made available by physicians. In the medical records, the 
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women stated that they underwent laparoscopic surgery (at some point in time, with the 
date of surgery noted) and were diagnosed with endometriosis following the procedure. 
Further, medical records from the pool of eligible women provided information regarding 
whether or not there currently was an issue with infertility.  
 The women who were eligible for this study were identified by number (ie., 
Patient 1, Patient 2, Patient 3, and so forth. Information concerning the date in which the 
patient underwent laparoscopic surgery, their current age, whether or not they had a 
history of uterine fibroids, where their sites of endometriosis occurred, and whether or 
not they experienced/had experienced issues with infertility were listed separately 
according to the patient. 
 Because that the target population was women between the ages of 18-35 years 
who had been diagnosed with endometriosis via laparoscopic procedure in Eastern North 
Carolina, the sample from the target population was retrieved by assessing the medical 
records of women who lived/visited a clinic in several of Eastern North Carolina’s largest 
counties: Pitt County, Wayne County, Lenoir County, Bladen County, Jones County, and 
New Hanover County.  
The target population was not restricted by race, as all racial/ethnic groups were 
considered. The sample size for this study consisted of 102 women who had been 
diagnosed with endometriosis. The sample size was calculated using G*Power version 
3.0.10 under the parameters 80% statistical power, an alpha of .05, and an effect size of 
.5. A statistical power of .80 was chosen so that I could find a real treatment effect (or 
mean difference) 80% of the time. For example, if the study were repeated 100 times, the 
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null hypothesis would be rejected 80 times–if there is indeed an effect (Burkholder, n.d.). 
An alpha level of .05 was used so that there would only be a 5% chance for making a 
Type I error, incorrectly rejecting the null hypothesis (Burkholder, n.d.). Last, the effect 
size of .5 simply was preferred to achieve a medium effect size. 
Sampling and Sampling Procedure 
Preexisting medical records from a sample of approximately 102 women of 
multiple races/ethnicities, residing in Eastern North Carolina, suffering from 
endometriosis was used for this study. The factor of race/ethnicity was not be considered 
for this study because similar rates of endometriosis are observed among women of 
different races (Gerlinger et al., 2012). Only women between the ages of 18 and 35 years 
were used for this study as such age group is considered to be within good standards in 
regard to reproduction, with women’s fertility decreasing substantially by their late 30s 
(Lezzoni et al., 2014). Women who are over the age of 35 were excluded to avoid the 
factor of age as a possibility for infertility. Preexisting medical records that were assessed 
were retrieved from OB-GYN clinics located in Eastern North Carolina. 
 Inclusion and exclusion criteria determined eligibility for the assessment of 
medical records of patients. Inclusion criteria were the following: women who were 
formally diagnosed with endometriosis (i.e., Stage I or Stage II) residing in Eastern North 
Carolina between the ages of 18-35, and women who provided full consent for their 
medical records to be assessed for research purposes. Diagnosis of endometriosis was 
assessed according to documentation in the medical records of each patient stating that 
the patient underwent laparoscopic surgery on a day within a certain year. Any other 
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diagnoses presented in the medical records–aside from diagnosis of uterine fibroids–were 
not be assessed. Exclusion criteria included the following: women who suspected 
endometriosis but had avoided formal diagnosis via laparoscopic procedure, women not 
between the ages of 18-35, women who did not provide full consent for their medical 
records to be assessed, and women diagnosed with Stage III (or moderate) or Stage IV (or 
severe). If there was no indication of laparoscopic surgery presented in a patient’s 
medical record (i.e., no documented date of laparoscopic surgery), such patient was 
excluded from the study, and if a patient was found to possess multiple locations of deep 
adhesions or implants (i.e., implants/adhesions involving multiple organs), those patients 
were excluded as well. 
As previously stated, the study consisted of preexisting medical records from a 
sample of 109 women. The sample size was calculated using G*Power version 3.0.10 
under the parameters 80% statistical power, an alpha of .05, and an effect size of .5. 
Given those parameters, it was suggested that the study contain a sample size of 102. I 
was, however, able to achieve a slightly higher sample size. My reasoning for choosing a 
statistical power of .80 was so I could insure a real treatment effect 80% of the time, 
rejecting the null hypothesis 80 times in the case that the study was repeated 100 times, if 
there was indeed an effect (Burkholder, n.d.). For there to only be a 5% chance for 
making a Type I error, or incorrectly rejecting the null hypothesis, an alpha level of .05 
was used. Last, the effect size of .5 simply was preferred to achieve a medium effect size.  
48 
 
Archival Data 
The data collection process for this study required institutional review board 
(IRB) approval to assess secondary data in the form of patient medical records from OB-
GYN clinics in Eastern North Carolina. IRB approval documents, along with the data use 
agreement form, were presented to physicians prior to the assessment of patient medical 
records. Physicians whom agreed to serve as my data provider signed the data use 
agreement form and asked me to sign a HIPAA confidentiality agreement form in the 
case that not all medical records were de-identified. Once the HIPAA confidentiality 
agreement forms were signed by physicians as well as myself, I was allowed temporary 
access to medical records of patients who suffered from and had been diagnosed with 
endometriosis. In the case that any patients were not diagnosed with endometriosis, their 
medical records remain nondisclosed to me. 
Data Analysis Plan 
The software that was used for the analysis of this study included IBM SPSS 
Statistics Version 24. SPSS was used to perform statistical regression analysis to assess 
the association between age of women when diagnosed with endometriosis (i.e., the 
independent variable) and infertility (i.e., the dependent variable). Furthermore, statistical 
regression analysis and stratified analysis was used to test for confounding by assessing 
the association between age of women when diagnosed with endometriosis and infertility 
when a second independent variable (e.g., history of uterine fibroids) was introduced. The 
research questions and hypotheses for this study included 
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RQ1: What is the association between infertility and age of women when 
diagnosed with endometriosis after controlling for history of uterine fibroids?  
H01: There is no statistically significant association between infertility and age of 
women when diagnosed with endometriosis after controlling for history of uterine 
fibroids. 
H11: There is a statistically significant association between infertility and age of 
women when diagnosed with endometriosis after controlling for history of uterine 
fibroids. 
RQ2: What is the association between infertility and age of women when 
diagnosed with endometriosis after controlling for the specific sites of endometriosis? 
H02: There is no statistically significant association between infertility and age of 
women when diagnosed with endometriosis after controlling for the specific sites of 
endometriosis. 
H12: There is a statistically significant association between infertility and age of 
women when diagnosed with endometriosis after controlling for the specific sites of 
endometriosis. 
The analysis included conducting multiple logistic regression to determine 
potential associations between variables. For example, age of women when diagnosed 
with endometriosis (i.e., age) served as the independent variable on a continuous scale, 
with ages ranging between 18 and 35 years. More specifically, ages of women were not 
be dichotomized into groups. Fertility status (i.e., infertility) served as the dependent 
variable on a binary scale where women were coded in the dataset as being fertile or 
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infertile (i.e., fertile=0; infertile=1). The variable history of uterine fibroids (i.e., uterine 
fibroids) was introduced as a potential confounding variable in the association between 
the variables age and infertility To test whether history of uterine fibroids might act as a 
confounding variable–affecting the association between age of women when diagnosed 
with endometriosis and infertility–a stratified analysis was performed to examine the 
primary association at different levels of the potential confounding variable. For example, 
the association between age of women when diagnosed with endometriosis and infertility 
was tested separately among women with a history of uterine fibroids and among women 
without a history of uterine fibroids. In the initial analysis, before the effect of history of 
uterine fibroids was taken into consideration, uterine fibroids was be coded in the dataset 
as 0=nonpresence of uterine fibroids and 1=presence of uterine fibroids. Patients who 
suffer from endometriosis often suffer from uterine fibroids as well, and both are 
considered to potentially lead to subfertility or infertility in women (Uimari et al., 2011). 
For the second research question, age of women when diagnosed with endometriosis (i.e., 
age) served as the independent variable on a continuous scale, and fertility status (i.e., 
infertility) served as the dependent variable. Instead of including the variable uterine 
fibroids into the analysis, implantation/site location of endometriosis (i.e., site) was 
included, with the variable coded (1=ovaries, 2=fallopian tubes, 3=uterus, 4=bladder, 5= 
rectum, etc.). 
The results were interpreted via scatterplots, which presented whether or not there 
was a statistically significant association between the age in which women are diagnosed 
with endometriosis and infertility. I also determined the usefulness of the logistic 
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regression model in terms of measuring the association between variables. 
Crosstabulation, or a contingency table analysis, was performed. Table 1 represents the 
aforementioned data analysis plan: 
Table 1 
Data Analysis Plan 
Research Questions Variables Statistical Analyses 
RQ1: What is the 
association between age of 
women when diagnosed 
with endometriosis and 
infertility after controlling 
for history of uterine 
fibroids? 
IV: Age when diagnosed 
with endometriosis. 
DV: Infertility 
Covariate: History of 
Uterine Fibroids 
Test: Logistic Regression; 
ANOVA; Crosstabulation  
RQ2: What is the 
association between age of 
women when diagnosed 
with endometriosis and 
infertility after controlling 
for specific sites of 
endometriosis? 
IV: Age when diagnosed 
with endometriosis. 
DV: Infertility 
Covariate: Site/Location of 
endometriosis  
Test: Logistic Regression; 
Crosstabulation 
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Access to Secondary Data 
Access to secondary data in the form of electronic patient medical records was 
obtained by contacting multiple clinics in Eastern North Carolina by both phone and e-
mail. After physicians at certain clinics agreed to allow me access to patient medical 
records, I personally met with each of the physicians at the clinics and presented them 
with a data use agreement form that was signed by myself, as well as the physicians who 
were responsible for granting me access to the medical records necessary for answering 
my research questions. All of the medical records used for the study were either de-
identified so that patients’ names, addresses, and other forms of contact information were 
not be available to me, or a HIPAA confidentiality form was signed to protect the 
identities of those whose charts were not de-identified. 
Threats to Validity 
External Validity 
External validity explains the extent to which conclusions can be generalized to a 
wider population and/or across populations, treatments, settings/contexts, and time 
(Laureate Education, 2012). External validity is important in quantitative research due to 
because researchers strive to be able to report that their conclusions gathered from their 
research can be generalized, although the results are based solely on a sample (Laureate 
Education, 2012). With quantitative research designs, the level of external validity is 
affected by potential threats that may influence the ability to make generalizations 
(Laureate Education, 2012). The four main threats to external validity in quantitative 
research include selection biases; constructs, methods, and confounding; real world 
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versus experimental world; and history effects and maturation (Laureate Education, 
2012). I stopped reviewing here. Please go through the rest of your chapter and look for 
the patterns I pointed out to you. I will now look at Chapter 4. 
 Given that this study included a secondary data analysis of existing 
medical records, selection bias could have been an issue given the fact that only medical 
records of women portraying specific factors, such as in age, race/ethnicity, marital 
status, and socioeconomic status were assessed (Laureate Education, 2012). Such threat 
to external validity, however, was addressed by assessing medical records of women of 
all races/ethnicities, marital statuses, socioeconomic statuses, and races/ethnicities. 
Assessing the medical records of women belonging to a wide variety of ages, ranging 
from the teens to mid-thirties, also addressed such threat to external validity. 
Furthermore, since extraneous variables also can limit the generalizability of results by 
studying only certain characteristics within a sample/population (i.e. endometriosis), such 
threat the validity was addressed by taking history of uterine fibroids into consideration 
when studying the association between the independent and dependent variables as well 
(Laureate Education, 2012). By addressing such threats, the sample is more generalizable 
to larger populations of women suffering from endometriosis, possibly facing infertility. 
Internal Validity 
Internal validity explains the extent to which our conclusions made from our 
dissertation research accurately reflect what we are studying (Laureate Education, 2012). 
With that being said, as researchers, we want to be able to state our conclusions with as 
much certainty as possible. In quantitative studies, internal validity can be affected by the 
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type of quantitative research design adopted (i.e. descriptive, experimental, etc.) and 
potential threats (Laureate Education, 2012). Threats to internal validity might include: 
instrumentation, selection bias, history effects, testing effects, statistical regression, and 
compensation (Laureate Education, 2012). Again, given that this study uses a secondary 
analysis of existing medical records, and no actual patients were needed for the study, 
internal validity was high. 
Construct Validity 
Construct validity refers to the extent to which a measurement procedure 
measures given constructs in a study (Laureate Education, 2012). In other words, 
construct validity is viewed as the process that researchers go through in order to assess 
the validity of a measurement procedure (e.g. questionnaire) when used to measure a 
given construct (e.g. depression, trust, commitment, etc.) (Laureate Education, 2012). For 
construct validity to exist, a clear link between the construct of interest and the measures 
and/or interventions used to operationalize it should be clear; and furthermore, a clear 
distinction between constructs should exist (Laureate Education, 2012). With that being 
said, there are a number of threats to construct validity, which include: inexact definitions 
of constructs, mono-operation bias, reducing levels of measurements of constructs, 
mono-method bias, treatment-sensitive factorial structure, and construct confounding 
(Laureate Education, 2012). 
In order to avoid such threats, broad constructs of interest were narrowed down 
and adequate definitions of constructs were provided. Furthermore, given that this study 
consisted of one independent variable (i.e. age) and one dependent variable (i.e. 
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infertility), taking into consideration the co-variates and potential confounding variables 
“uterine fibroids” and “sites/locations,” threats to construct validity in regards to 
construct confounding were addressed by thoroughly explaining how the constructs 
uterine fibroids and endometriosis relate to one another, as well as explaining the 
boundaries between the two, and how differences in site/location of endometriosis 
provide for different outcomes (Laureate Education, 2012). 
Ethical Procedures 
In order to ensure that the study was conducted ethically, the protection of 
patients whose medical records were assessed was taken highly into consideration. This 
study was conducted in compliance with ethical standards provided by Walden 
University. Informed consent and the assessment of medical records received Walden 
IRB approval prior to the initiation of the study. For example, IRB was contacted via e-
mail, and all study procedures (e.g. requirement of obtaining de-identified patient medical 
records) were presented to IRB prior to data collection. As suggested by IRB, a Data Use 
Agreement form was signed by myself as well as physicians as an agreement to gain 
temporary access to patient medical records for use in research in accord with laws and 
regulations of the governing bodies associated with the Data Provider (i.e. physicians), 
Data Participant (i.e. myself), and Data Participant’s educational program (i.e. Walden 
University). The signed Data Use Agreement document was submitted along with my 
IRB application, which was formally approved before any data was assessed. Patient 
medical records remained inside the clinics at all times during the assessment process. 
Furthermore, I was not allowed to leave the clinics with any medical records at any time 
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as to ensure confidentiality and avoid dissemination. As the student researcher, I was the 
only individual allowed access to the medical records aside from the physicians of the 
clinics. Importantly, the names, addresses, and telephone numbers of patients whose 
medical records were assessed were not disclosed in the study. The IRB approval number 
for this study is: 07-11-17-0561657. 
Summary 
In this chapter, I discussed the research design, methodology, data collection and 
analysis plan, threats to validity and ethical considerations associated with the study. A 
detailed explanation of how this study was conducted in order to obtain and gather the 
data necessary to determine whether or not an association exists between the age in which 
a woman is diagnosed with endometriosis and infertility was provided. The purpose of 
this study, which was to fill the gap concerning whether an association exists between the 
time in which a woman is diagnosed with endometriosis (i.e. age of woman when 
diagnosed) and infertility was thoroughly explained. In Chapter 4, I will present the 
results of the analysis of the data collected in the study. 
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Chapter 4: Results  
Introduction 
The purpose of this study was to determine whether an association between the 
age of women when diagnosed with endometriosis and infertility existed. Both uterine 
fibroids and endometriosis are known to lead to subfertility or infertility in women; yet, 
the relationship between the two is poorly understood. In this study, I also aimed to 
determine whether an association between the age of women when diagnosed with 
endometriosis and infertility existed when history of uterine fibroids also was present. 
Further, given that site/location of endometrioma might affect the association between 
infertility and the age in which a woman is diagnosed with endometriosis, I also aimed to 
determine the affect different sites/locations have when assessing the relationship 
between infertility and the age in which a woman is diagnosed with endometriosis.  
The research questions this study aimed to answer included the following:  
RQ1: What is the association between infertility and age of women when 
diagnosed with endometriosis after controlling for history of uterine fibroids?  
H01: There is no statistically significant association between infertility and age of 
women when diagnosed with endometriosis after controlling for history of uterine 
fibroids. 
H11: There is a statistically significant association between infertility and age of 
women when diagnosed with endometriosis after controlling for history of uterine 
fibroids. 
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RQ2: What is the association between infertility and age of women when 
diagnosed with endometriosis after controlling for the specific sites of endometriosis? 
H02: There is no statistically significant association between infertility and age of 
women when diagnosed with endometriosis after controlling for the specific sites of 
endometriosis. 
H12: There is a statistically significant association between infertility and age of 
women when diagnosed with endometriosis after controlling for the specific sites of 
endometriosis. 
In Chapter 4, I will present the findings of this study, as well as the data collection 
process. The sample size for this study was calculated using G*Power version 3.0.10 
under the parameters 80% statistical power, an alpha of .05, and an effect size of .5. A 
statistical power of .80 was chosen so that I could expect to find a real treatment effect 
(or mean difference) 80% of the time. An alpha level of .05 was used so that there would 
only be a 5% chance for making a Type I error, incorrectly rejecting the null hypothesis 
(Burkholder, n.d.). Last, the effect size of .5 simply was preferred to achieve a medium 
effect size. An accurate sample size for the study consisted of 102 women diagnosed with 
endometriosis. After collecting necessary data, however, I was fortunate to receive data 
on a total of 109 who satisfied my inclusion criteria. 
Data Collection 
The data for this study were collected over a period of 3 weeks, with the time 
frame ranging from December 4, 2017 to December 22, 2017. Although I was able to 
retrieve the data in a short period of time, the process for meeting all requirements by the 
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clinics/hospitals before the actual retrieval of data was permitted was lengthy. For 
example, to retrieve data from the clinics/hospitals, I was required to receive several 
vaccinations and present proof of updated vaccination records, and I also was required to 
present both a state and federal level background check to each of the clinics/hospitals. 
Although I received my state background check within a few weeks, retrieval of my 
federal background check took a total of 4 months to receive, having applied for one in 
July 2017 and not receiving feedback from the FBI until the end of October 2017. 
Without both the state and federal background checks presented to the hospitals/clinics, 
physicians were unable to sign my data use agreement forms, which were required to 
complete my IRB application.  
Once IRB permitted me to proceed with the collection of my data, all physicians 
were immediately contacted, and all physicians worked around their schedules to 
accommodate my needs. After I visited with all clinics/hospitals approved in my IRB 
application, a total of 109 participants were assessed for this study. All of the participants 
were women between the ages of 18 and 35 who were diagnosed with endometriosis via 
laparoscopic procedure. Any medical charts gathered for my assessment that included 
women outside of the inclusion criteria were excluded from the study. For example, 
several participants, I found, were not within the age criteria, and some participants 
presented to physicians with suspicion of endometriosis, but never underwent 
laparoscopic procedure to confirm a diagnosis. The final analysis of this study was 
conducted on 109 patients, with a power analysis conducted to calculate achieved power, 
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using an appropriate alpha level (α = .05), sample size (n = 109), and effect size (η2 = .5). 
The achieved power was calculated to be 0.80. 
All data retrieved for this study consisted of preexisting medical records from a 
sample of 109 women of multiple races/ethnicities, residing in Eastern North Carolina, 
who suffered from endometriosis. The factor of race/ethnicity was not considered in this 
study because similar rates of endometriosis are observed among women of different 
races (Gerlinger et al., 2012). Only women between the ages of 18 and 35 years were 
used for this because such an age group is considered to be within good standards in 
regard to reproduction, with women’s fertility decreasing substantially by their late 30s 
(Lezzoni et al., 2014). Women over the age of 35 were excluded from the study to avoid 
the factor of age serving as a possibility for infertility. I did not include data on women 
who possessed multiple locations of deep adhesions or implants (i.e., implants/adhesions 
involving multiple organs), as I wanted to compare how site/location of endometrioma 
might affect the association between infertility and the age in which a woman was 
diagnosed with endometriosis, separately. All medical records assessed were retrieved 
from OB/GYN clinics/hospitals located in Eastern North Carolina. 
 Because this study included a secondary data analysis of existing medical records, 
selection bias could have been an issue if only medical records of women portraying 
factors (ie., in age, race/ethnicity, marital status, and socioeconomic status) were assessed 
(Laureate Education, 2012). Such threat to external validity, however, was addressed by 
assessing medical records of women of all races/ethnicities, marital statuses, 
socioeconomic statuses, and races/ethnicities. Assessing the medical records of women 
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belonging to a wide variety of ages, ranging from the teens to mid-30s, also addressed 
such threats to external validity. Furthermore, because extraneous variables also can limit 
the generalizability of results by studying only certain characteristics within a 
sample/population (i.e., endometriosis), such threats the validity were addressed by 
taking history of uterine fibroids into consideration when studying the association 
between the independent and dependent variables (Laureate Education, 2012). By 
addressing such threats, the sample was more generalizable to larger populations of 
women suffering from endometriosis, possibly facing infertility. 
Results 
Descriptive Statistics 
Participant characteristics. As part of the inclusion criteria, all participants were 
required to be between the ages of 18 and 35 years and had had been diagnosed with 
endometriosis, with diagnoses having been documented in the medical records of each 
patient. All patients with the presence of uterine fibroids–along with their diagnosis of 
endometriosis–were gathered from documentation in the medical records. Descriptive 
statistics for the continuous variable age are presented in Table 2.  
Table 2 
Descriptive Statistics 
 N 
 
Minimum Maximum Mean Median Std. 
Deviation 
Age 109 18 35 28.59 29 5.403 
 
Frequencies and percentages for age. Out of 109 participants aged 18 to 35 
years, the most common age at time of diagnosis was 35 years, with 17 women (15.6%) 
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being aged 35 when diagnosed with endometriosis. The second most common age at time 
of diagnosis was 33 years, with 14 women (12.8%) being aged 33 when diagnosed with 
endometriosis. In turn, the least common age at time of diagnosis was 23 years, with only 
one patient (0.9%) being 23 when diagnosed with endometriosis. The frequency for age 
is presented in Table 3.   
Table 3 
Frequency for Age 
Age Frequency 
 
Percent (%) 
18 4 3.7 
19 7 6.4 
20 3 2.8 
21 2 1.8 
22 7 6.4 
23 1 0.9 
25 4 3.7 
26 6 5.5 
27 7 6.4 
28 8 7.3 
29 7 6.4 
30 6 5.5 
31 5 4.6 
32 3 2.8 
33 14 12.8 
34 8 7.3 
35 17 15.6 
 
Frequencies and percentages for fertility status. Out of 109 participants, only 
30 participants (27.5%) were considered to be suffering from infertility, while 79 
participants (72.5%) expressed no concerns of infertility, despite endometriosis diagnosis. 
The frequency for fertility status is presented in Table 4. 
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Table 4 
Frequency for Fertility Status 
Fertility Status Frequency 
 
Percent (%) 
Fertile 79 72.5 
Infertile 30 27.5 
Total 109 100.0 
   
 
Frequencies and percentages of site/implantation. Out of 109 participants, the 
most frequent location for endometriosis occurred equally amongst the ovaries and the 
fallopian tubes, with 34 participants (31.2%) found to have endometrioma on their 
ovaries and 34 participants (31.2%) found to have endometrioma on their fallopian tubes. 
The least frequent location amongst the study sample was the rectum, with only two 
(1.8%) participants found to have endometrioma located on their rectum. By assessing 
the frequencies for the site/locations of endometrioma amongst the study sample, I 
determined that two of the five site/locations (i.e., bladder and rectum) had low cell 
counts when a crosstabulation is performed. The frequencies for site/location of 
endometrioma is presented in Table 5. 
Table 5 
Frequencies for Site/Location of Endometrioma 
Site/Location Frequency 
 
Percent (%) 
Ovaries 34 31.2 
Fallopian 
Tubes 
34 31.2 
Uterus 28 25.7 
Bladder 11 10.1 
Rectum 2 1.8 
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Total 109 100.0 
 
Frequencies and percentages of uterine fibroids. Out of 109 participants diagnosed 
with endometriosis, only 14 women (12.8%) had reported uterine fibroids. The majority 
of endometriosis patients in the sample, consisting of the remaining 95 women (87.2%), 
had not reported uterine fibroids. The frequency for uterine fibroids is presented in Table 
6. 
Table 6 
Frequency for Uterine Fibroids 
Uterine 
Fibroids 
Frequency 
 
Percent (%) 
No 95 87.2 
Yes 14 12.8 
Total 109 100.0 
   
 
Analysis of variance of the data. One-way ANOVA was performed for age and 
fertility status. The number of fertile woman in the sample was 79, with the mean age 
being 27.51 years, which presented a lower bound of 26.22 years and an upper bound of 
28.79 years. The number of infertile women in the sample was 30, with the mean age 
being 31.43 years, which presented a lower bound of 30.32 years and an upper bound of 
32.55 years. Further, the minimum age for those women considered fertile was 18 years, 
while the maximum age was 35 years. The minimum age for those women considered 
infertile, however, was 26 years; although, the maximum age also was 35 years. 
According to the ANOVA statistics, on average, the fertile women were of younger age 
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when diagnosed with endometriosis than the infertile women. The p-value was found to 
be statistically significant with p=.001. The means are presented in Table 7. 
Table 7 
ANOVA Descriptives 
A
g
e 
     95% 
for  
C.I 
Mean 
  
  N Mean St. 
deviation 
 
St. 
Error 
Lower 
Bound 
Upper 
bound 
Minimum Maximum 
 Fertile 79 27.51 5.735 .645 26.22 28.79 18 35 
 Infertile 30 31.53 2.979 .544 30.32 32.55 26 35 
 Total 109 28.59 5.408 .518 27.56 29.61 18 35 
Note. (P=.001) 
 
A contingency table analysis for uterine fibroids and fertility status was 
performed. Regarding the entire study population (n=109), it was determined that the 
majority of the fertile population (78.9%) did not have a presence of uterine fibroids, and 
only 28.6% of the fertile population did have a presence of uterine fibroids. Further, it 
was determined that the majority of the infertile population (71.4%) did have a presence 
of uterine fibroids, with only 21.1% of the infertile population not having a presence of 
uterine fibroids. From the crosstab results, amongst the study sample, women diagnosed 
with endometriosis who also have fibroids were more likely to be infertile. The p-value 
was calculated to be .000, which was statistically significant. Therefore, there was a 
statistically significant association between uterine fibroids and fertility status. The 
crosstabulation for uterine fibroids and fertility status is presented in Table 8.  
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Table 8 
Fibroids and Fertility Status Crosstabulation 
Fibroids 
 
Frequencies Fertile 
 
Infertile Total 
 
No 95 78.9% 21.1% 100.0% 
Yes 14 28.6% 71.4% 100.0% 
Total 109 72.5% 27.5% 100.0% 
Note. (P=.000) 
 Last, a contingency table analysis for site/location of implantation of 
endometrioma and fertility status was performed. Regarding the participants who were 
considered to be facing issues with infertility (n=30), the majority (44.1%) experienced 
endometrioma on their ovaries, followed by 41.2% of the infertile having experienced 
endometrioma on their fallopian tubes, and only 3.6% of the infertile having experienced 
endometrioma on their uterus. None (of the infertile participants [0.0%]) were found to 
be suffering from endometrioma on their bladder or rectum. From the crosstab, there was 
a small cell count for location of endometrioma on the bladder and on the rectum (e.g., 
expected count <5). The p-value for the Fisher’s Exact Test was calculated to be .000, 
which was statistically significant. Therefore, there was a statistically significant 
association between site/location of implantation of endometrioma and fertility status. 
The crosstabulation for uterine fibroids and fertility status is presented in Table 9. 
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Table 9 
Implantation and Fertility Status Crosstabulation Fisher’s Exact 
Site/Implantation 
Location 
 
Frequencies Fertile 
 
Infertile Total 
 
Ovaries 34 55.9% 44.1% 100.0% 
Fallopian Tubes 34 58.8% 41.2% 100.0% 
Uterus 28 96.4% 3.6% 100.0% 
Bladder 11 100.0% 0.0% 100.0% 
Rectum 2 100.0% 0.0% 100.0% 
Total 109 72.5% 27.5% 100.0% 
Note. (P=.000) 
Research Question 1 
What is the association between age of women when diagnosed with 
endometriosis and infertility after controlling for history of uterine fibroids? 
Hypothesis 1 
 Null hypothesis: There is no statistically significant association between age of 
women when diagnosed with endometriosis and infertility after controlling for history of 
uterine fibroids. 
Alternative hypothesis: There is a statistically significant association between age 
of women when diagnosed with endometriosis and infertility after controlling for history 
of uterine fibroids. 
Infertility and age when diagnosed with endometriosis. A logistic regression was 
performed to determine the effects of the independent variable (i.e. age when diagnosed 
with endometriosis) on the likelihood that participants suffer with infertility without 
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considering the effects of the covariates (i.e. history of uterine fibroids, site/location of 
endometrioma).  
 The model summary determined a -2 Log likelihood of 115.182a, with a Cox and 
Snell R square of .113 and a Nagelkerke R square of .164. These statistics provide 
incentive that 11.3%-16.4% of the variability in the dependent variable (i.e. infertility) is 
accounted for by the independent variable (i.e. age when diagnosed with endometriosis). 
The model summary table is presented in Table 10. 
Table 10 
Model Summary 
Step -2 Log 
likelihood 
 
Cox & 
Snell R 
Square 
Nagelkerke 
R Square 
1 115.182a .113 .164 
    
 
 A Hosmer and Lemeshow test was performed, which presented a chi-square of 
9.658 and a p-value of .209. Given that the p-value is greater than .05, we learn that the 
model is significant in regard to the data. The Hosmer and Lemeshow test is presented in 
Table 11. Furthermore, given concern for which participants are considered to be infertile 
and whether or not the predictor variables are predicting infertility, the differences 
between observed and expected fertile versus infertile participants were calculated. 
Observing the differences between the observed and expected fertile versus infertile 
patients, again, provides evidence that there is no indication of poor fit in regard to the 
model; with the model, for example, predicting ~9 (8.782) out of 11 participants’ fertility 
status. The contingency table for the Hosmer and Lemeshow test is presented in Table 12 
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Table 11 
Hosmer and Lemeshow Test 
Step Chi-
square 
 
Df Sig. 
1 9.658 7 .209 
    
 
Table 12 
Contingency Table for Hosmer and Lemeshow Test 
 Fertile  Infertile   
 Observed 
 
Expected Observed Expected Total 
1 11 10.392 0 .608 11 
2 12 10.979 0 1.021 12 
3 9 9.291 2 1.709 11 
4 12 11.863 3 3.137 15 
5 6 9.514 7 3.486 13 
6 4 5.310 4 2.690 8 
7 10 8.400 4 5.600 14 
8 4 4.470 4 3.530 8 
9 11 8.782 6 8.218 17 
.  
The overall predictive capacity of the model when only looking at the association 
between the independent variable (i.e. age) and the dependent variable (i.e. infertility) 
was determined to be 72.5%, which indicates that although the model is not strong, it is 
significant. The classification table is presented in Table 13. 
Table 13 
Classification Table 
Observed  Fertile Infertile Percentage 
Correct 
Fertility Fertile 79 0 100.0 
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 Infertile 30 0 .0 
Overall 
Percentage 
   72.5 
 
Again, the B value for age was found to be .170, which can be interpreted to mean 
that greater values of age at time of diagnosis (e.g. increases in age) are associated with 
greater probability of being infertile. In other words, a 1-unit (e.g. 1-year) increase in age 
is associated with a .170 increase in the logit variable – or the probability of being 
infertile. Given that the p-value for age is .001, the variable is still considered to be a 
statistically significant predictor of infertility. Last, with an odds ratio of 1.185, it can 
further be concluded that a 1-unit (e.g. 1-year) increase in age is associated with a 1.185 
times greater odds of experiencing infertility. Importantly, the analysis was interpreted 
with the variable “age” being measured on a continuous scale – with ages ranging from 
18-35 years. In other words, the variable “age” was not categorized in to specific age 
groups. With that being said, it is appropriate to report that compared to a woman 
diagnosed with endometriosis at age 18 years, a woman diagnosed with endometriosis at 
age 35 years has a higher odds of experiencing infertility. Variables in the equation are 
presented in Table 14. 
 
Table 14 
Variables in the Equation 
       95%  
for 
C.I. 
Exp(B) 
 B 
 
S.E. Wald Df Sig. Exp(B) Lower Upper 
Age .170 .053 10.153 1 .001 1.185 1.067 1.315 
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Constant -6.001 1.649 13.249 1 .000 .002   
 
Presence of uterine fibroids. A logistic regression was performed, taking the 
covariate “uterine fibroids” into consideration in order to determine the effects of the 
independent variable (i.e. age when diagnosed with endometriosis) on the likelihood that 
participants suffer with infertility. With the variable “uterine fibroids” present, the odds 
ratio for age experienced a slight decrease, but remained statistically significant (p-
value=.011), and the odds ratio for fibroids was 6.300, which also was found to be 
statistically significant (p-value=.006). With an Exp(B) of 6.300, we learn that patients 
with uterine fibroids have a 6.3 times greater odds of having infertility after controlling 
for age. In other words, presence of uterine fibroids was found to be a stronger 
independent predictor than age. Importantly, the results showed that the odds of infertility 
are higher for the women in the study sample who were diagnosed at an older age even 
after adjusting for fibroids. Variables in the equation are presented in Table 15. 
Table 15 
Variables in the Equation 
       95%  
for 
C.I. 
Exp(B) 
 B 
 
S.E. Wald Df Sig. Exp(B) Lower Upper 
Age .141 .055 6.530 1 .011 1.151 1.033 1.282 
Fibroids 1.841 .666 7.641 1 .006 6.300 1.708 23.232 
Constant -5.426 1.684 10.384 1 .001 .004   
 
A Hosmer and Lemeshow test was performed after the variable “uterine fibroids” 
was introduced, which presented a chi-square of 14.317 and a p-value of .074. Given that 
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the p-value is greater than .05, again, we learn that the model adequately describes the 
data. The Hosmer and Lemeshow test is presented in Table 16. Given concern for which 
participants are considered to be infertile and whether or not the predictor variables are 
predicting infertility when presence of uterine fibroids is introduced, the differences 
between observed and expected fertile versus infertile participants were calculated. 
Again, the contingency table for the Hosmer and Lemeshow test provides evidence that 
there is no indication of poor fit in regard to the model; with the model, for example, 
predicting 4 out of 4 participants’ fertility status as being fertile and predicting 10 out of 
10 participants’ fertility status as being infertile. The contingency table for the Hosmer 
and Lemeshow test is presented in Table 17. 
Table 16 
Hosmer and Lemeshow Test 
Step Chi-
square 
 
Df Sig. 
1 14.317 8 .074 
    
 
Table 17 
Contingency Table for Hosmer and Lemeshow Test 
 Fertile  Infertile   
 Observed 
 
Expected Observed Expected Total 
1 11 10.371 0 .629 11 
2 12 11.020 0 .980 12 
3 8 7.785 1 1.215 9 
4 12 12.379 3 2.621 15 
5 6 9.381 6 2.619 12 
6 4 5.124 3 1.876 7 
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7 9 6.868 1 3.132 10 
8 3 4.591 4 2.409 7 
9 10 7.481 2 4.519 12 
10 4 4.000 10 10.000 14 
 
Research Question 2 
 What is the association between age of women when diagnosed with 
endometriosis and infertility after controlling for specific sites of endometriosis? 
Hypothesis 1 
 Null hypothesis: There is no statistically significant association between age of 
women when diagnosed with endometriosis and infertility after controlling for specific 
sites of endometriosis. 
 Alternative hypothesis: There is a statistically significant association between age 
of women when diagnosed with endometriosis and infertility after controlling for specific 
sites of endometriosis. 
 Site/location of endometrioma. A logistic regression was performed, taking the 
covariate “site/implantation” into consideration in order to determine the effects of the 
independent variable (i.e. age when diagnosed with endometriosis) on the likelihood that 
participants suffer with infertility. Specifically, dummy variables were made for each 
site/location (i.e. implantation(1)=ovaries; implantation(2)=fallopian tubes; 
implantation(3)=uterus; and implantation(4)=bladder) except for the dummy variable 
“rectum”, which was used as a reference category. Output from the logistic regression, 
however, showed that the model was poorly fit. The logistic regression for fertility status 
and site/location of implantation is presented in Table 18.  Further, the chi-square test 
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also provided indication of poor fit, with three cells (30%) having an expected count of 
less than 5. The chi-square test is provided in Table 19. Therefore, testing research 
question 2 was not possible. However, referencing back to Table 9, the contingency table 
analysis for implantation and fertility, the only information we can gather in regards to 
RQ2 is that out of the participants who were considered to be facing issues with infertility 
(n=30), the majority (44.1%) experienced endometrioma on their uterus, which was 
proceeded by 41.2% of the infertile participants having experienced endometrioma on 
their fallopian tubes, and then only 3.6% of the infertile participants having experienced 
endometrioma on their uterus. Interestingly, none of the infertile participants (0.0%) were 
found to be suffering from endometrioma specifically on their bladder or rectum. 
Importantly, the p-value was calculated to be .000, which is statistically significant. From 
that, the only conclusion that can be made from those results – in regard to the second 
research question – are that there is a statistically significant association between 
site/location of implantation of endometrioma and fertility status amongst the study 
sample. 
Table 18 
Logistic Regression for Variables in the Equation 
       95%  
for 
C.I. 
Exp(B) 
 B 
 
S.E. Wald Df Sig. Exp(B) Lower Upper 
Age .206 .072 8.247 1 .004 1.228 1.068 1.414 
Implantation   9.969 4 .041    
Implantation(1) 21.214 26465.582 .000 1 .999 1633916054 .000  
Implantation(2) 20.860 26465.582 .000 1 .999 1146835331 .000  
Implantation(3) 16.819 26465.582 .000 1 .999 20150132.92 .000  
Implantation(4) .272 28703.660 .000 1 1.000 1.313 .000  
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Fibroids 2.630 1.120 5.516 1 .019 13.847 13.847 124.567 
Constant -
27.650 
26465.582 .000 1 .999 .000 .000  
 
Table 19 
Chi-Square Statistics 
 Value 
 
Df Asymptotic 
Significance 
(2-sided) 
 
Pearson Chi-
Square 
20.860 4 .000 
Likelihood Ratio 26.909 4 .000 
Linear-by-Linear 
Association 
16.710 2 .000 
N of Valid Cases 109 27.5% 100.0% 
a. 3 cells (30.0%) have expected count less than 5. The minimum expected count is .55. 
 
Summary 
 The purpose of the study was to determine whether an association exists between 
the time in which a woman is diagnosed with endometriosis (i.e. age of woman when 
diagnosed) and infertility after controlling for covariates of site/location of implantation 
of endometrioma (i.e. implantation) and presence of uterine fibroids (i.e. fibroids). In 
regard to RQ1, it was determined that a statistically significant association exists between 
age of women when diagnosed with endometriosis and infertility after controlling for 
history of uterine fibroids; thus, the null hypothesis for research question one was 
rejected. However, in regard to RQ2, due to low cell counts for the nominal variable 
“site/location” of endometrioma, the desired logistic regression analysis was not valid; 
hence, making it impossible to answer research question two. Only from the contingency 
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table analysis (Table 8) regarding RQ2 could it be concluded that there is a statistically 
significant association between site/location of implantation of endometrioma and 
fertility status amongst the study sample, with higher percentages of endometrioma found 
on the ovaries and fallopian tubes amongst those women considered to be infertile; lower 
percentages of endometrioma found on the uterus amongst those women considered to be 
infertile; and no reports of endometrioma located on the bladder or rectum amongst those 
women considered to be infertile (p=.000).  
The findings of this study will be discussed further in Chapter 5, comparing the 
results and the statistical findings to existing literature. Chapter 5 also will provide a 
detailed discussion concerning the limitations of the study, implementing incentive for 
future research on the current study topic.   
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this quantitative, cross-sectional study was to determine whether 
association existed between the age of women when diagnosed with endometriosis and 
infertility after controlling for the covariates site/location of implantation of 
endometrioma and presence of uterine fibroids among women in Eastern North Carolina. 
Diagnosis of endometriosis has been found to be delayed anywhere from 7-10 years and 
is considered to be poorly recognized by physicians in practice, often leading to 
misdiagnosis and/or suboptimal care (Johnston et al., 2015). Earlier diagnoses of the 
disease (e.g., diagnosis at an earlier age) could serve as a preventative strategy towards 
infertility.  
Before this study, the age of women when diagnosed with endometriosis and the 
effects age at time of diagnosis might have on likelihood of infertility had not been 
studied (American Society for Reproductive Medicine, 2012). The findings of the study 
are expected to provide more information about the disease. Further, the study may 
supply readers with knowledge regarding the topic, which is expected to better help 
individuals recognize and understand normal menstrual cycles versus abnormal menstrual 
cycles, as well as normal symptoms associated with menstrual cycles versus serious 
abnormal pain that can be linked to endometriosis.  
I took a quantitative approach, which was appropriate for measuring an 
association between variables (Creswell, 2013). The cross-sectional design consisted of a 
secondary data analysis of existing medical records of patients formally diagnosed with 
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endometriosis. Logistic regression analysis was performed with age acting as the 
independent variable, fertility acting as the dependent variable, and fibroids and location 
of endometrioma acting as covariates. A contingency table analysis also was performed 
to determine which age group(s) and which site(s)/location(s) were most commonly 
associated with infertility.  
In the findings of the study, I found a statistically significant association between 
infertility and age in which a woman is diagnosed with endometriosis exists. Further, 
there was no indication of evidence of poor fit regarding the model used to determine the 
association between variables. The covariates, uterine fibroids, and site/location of 
implantation of endometrioma were both found to influence the association between 
infertility and the age in which a woman is diagnosed with endometriosis. 
Interpretation of the Findings 
The overall scope of the study was to determine the association between infertility 
and the age in which a woman is diagnosed with endometriosis. The population of this 
study consisted of 109 women aged 18 to 35 years. The most common age at time of 
diagnosis within the study population was found to be the oldest age in the study sample 
(i.e., 35 years), with 17 women (15.6%) being aged 35 years when diagnosed with 
endometriosis. The second most common age at time of diagnosis within the study 
population was 33 years, with 14 women (12.8%) being aged 33 years when diagnosed 
with endometriosis, which also is one of the oldest ages at time of diagnosis within the 
study population. The least common age at time of diagnosis was 23 years, with only one 
patient (0.9%) being aged 23 years when diagnosed with endometriosis. In contrast to the 
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most common age at time of diagnosis (i.e., 35 years), which also was the oldest age 
considered in the study population, age 23 years at time of diagnosis was one of the 
youngest ages at time of diagnosis within the study population. Further, the youngest age 
at time of diagnosis in the study population (i.e., 18 years), accounted for only four of the 
109 participants in the study population (3.7%). These frequency statistics for ages at 
time of diagnosis for the study population can be considered consistent with claims that 
endometriosis diagnoses are delayed (i.e., diagnosed at a later age opposed to a younger 
age). Many patients claim to have a long history of doctor visits due to lower abdominal 
and pelvic pain, receiving no support from physicians in regard to the pain aside from 
being written a prescription for painkillers (Johnston et al., 2015). The frequency 
statistics for ages at time of diagnosis for the study population reflected such claims given 
that older ages (i.e., 33-35 years) at time of diagnosis were more common than younger 
ages (i.e., 18-23 years) at time of diagnosis. 
Uterine fibroids and endometriosis may be associated with each other (Nezhat et 
al., 2016; Uimari et al., 2011). Although uterine fibroids seldom are the sole cause of 
infertility in women, they become a concern when coexisting with endometriosis, 
especially because of significant overlap of symptoms between endometriosis and uterine 
fibroids when it is difficult to discern which pathology is responsible for patients’ 
complaints (Nezhat et al., 2016). Further, patients who suffer from both endometriosis 
and uterine fibroids have an increased risk for infertility, which is thought to be due to 
influences related to the association between the two conditions (Ciavattini et al., 2013). 
The first research question addressed in this study included the following: What is the 
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association between infertility and age of women when diagnosed with endometriosis 
after controlling for history of uterine fibroids?  
Although I found that most of the population considered to be suffering with 
infertility did not have a history of uterine fibroids (66.7%), in a logistic regression 
analysis, I determined that patients within the study population had a 6.3 times greater 
odds of having infertility based on age when diagnosed with endometriosis when a 
history of uterine fibroids was present, than when based off age of diagnosis alone. 
Further, the value associated with the effects of uterine fibroids on the association 
between age at time of diagnosis and infertility was found to be statistically significant 
(p-value=.006).  
The most common phenotypes of endometriosis among women is superficial 
endometriosis, with sites of endometrioma located in the pelvic area, most commonly 
presented on and below the ovaries (Menakaya et al., 2014). Variation in the sites of 
endometrioma and how those s sites may or may not affect chances of infertility are 
lacking (Maggiore et al., 2016). The second research question addressed in this study 
included the following: What is the association between infertility and age of women 
when diagnosed with endometriosis after controlling for the specific sites of 
endometriosis? 
The frequency analysis for site/location of implantation of endometrioma was 
found to be consistent with the literature in that the majority of the 109 participants 
(31.2%) in the study population had an area of concern located on the ovaries. However, 
the exact same percentage of participants (31.2%) in the study population had an area of 
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concern located on the fallopian tubes. Disease affecting the fallopian tubes accounts for 
nearly 25%-35% of all infertility cases (Pereira & Kilgman, 2016). In the contingency 
table analysis for site/location of implantation of endometrioma and infertility, I found 
that out of the 30 participants who were considered to be infertile, the majority, or 15 out 
of 30 (50%), had endometrioma located on the ovaries, where 14 out of 30 (46.7%) 
participants who were considered to be infertile had endometrioma located on the 
fallopian tubes. I stopped reviewing here. Please go through the rest of your chapter and 
look for the patterns I pointed out to you. I will now look at your references. 
Beyond the scope of the literature, however, the association between infertility 
and the age in which a woman is diagnosed with endometriosis when considering the 
covariate “site/location” of implantation of endometrioma could not be determined from 
this study given the inability to answer research question two due to low cell count for the 
nominal variable “site/location”. However, from the contingency table analysis, it could 
be concluded that there is a statistically significant association between site/location of 
implantation and fertility status (p=.000).  
Limitations of the Study 
This study contained several limitations. The first limitation includes the fact that 
this study uses a secondary analysis of existing data. One major limitation regarding the 
conducting of a secondary analysis of existing data includes the fact that the data was not 
originally collected to address the particular research question or to test the particular 
research hypotheses (Cheng & Phillips, 2014). Another major limitation regarding the 
conducting of a secondary analysis of existing data for this study includes the fact that I, 
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as the researcher, was not involved in the initial data collection process; therefore, being 
unaware of any nuances in the data collection process that might be important to the 
interpretation of the key variables (Cheng & Phillips, 2014). A third limitation relates to 
the fact that race/ethnicity among women whose medical charts were assessed was not 
taken into consideration. Perhaps the association between the age in which a woman is 
diagnosed with endometriosis and infertility, even after taking the covariates site/location 
of implantation of endometrioma and presence of uterine fibroids into consideration, 
might differ when the factor of race is considered, even though endometriosis rates are 
considered to be very similar among races (Gerlinger et al., 2012). A fourth limitation 
relates to the fact that marital status of women whose medical charts were assessed also 
was not taken into consideration. Perhaps such sociodemographic variable could 
influence fertility status among the study population given that married couples are more 
likely to try to conceive than unmarried couples (Laplante, & Fostik, 2015). For example, 
given that some of the younger participants in the study population (i.e. 18-21 years) 
might not be married and/or trying to conceive, the status from their medical charts 
stating that they are considered to not be infertile (or not struggling with infertility issues) 
might not be accurate given that they might not be at a stage in their lives where they are 
trying to have a baby or are even sexually active. The most important limitation to 
consider for this study is the fact that there simply were not enough cases in the study 
sample. Had there been more cases, it is likely that there would have been a higher cell 
count for the specific site/locations of endometrioma that currently are lacking. Due to 
low cell count for the variable site/location of implantation of endometrioma, research 
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question two simply could not be answered. As previously mentioned, perhaps more 
controls such as race and marital status – to name a few – could have contributed to the 
relevance of this study. 
Recommendations 
I have a few recommendations for further study. The first recommendation for 
further study involves repeating this study with a broader cross-section among study 
participants. For example, a larger sample size might strengthen the generalization of the 
study results in regard to how accurately they reflect and represent a broader population. 
The second recommendation for further study involves introducing more covariates to be 
considered when assessing the association between infertility and the age in which a 
woman is diagnosed with endometriosis. Introduction of more covariates could, for 
example, further control for any potential confounding effects on the association between 
variables. In other words, I would recommend taking race/ethnicity into consideration, as 
race/ethnicity might have effects on infertility, alone. Further, taking marital/relationship 
status into consideration might affect whether an individual is sexually active or not; 
hence, trying to conceive versus not trying to conceive. Such covariate could better 
represent the fertility status of participants, especially given that single participants might 
not be evaluated to be suffering from infertility, but given their marital/relationship 
status, may actually be unaware of infertility due to not being sexually active and/or not 
trying to conceive. For example, there were study participants in my sample population 
who were diagnosed with endometriosis but not documented to be suffering from 
infertility. With that said, it is possible that the data used for this study is flawed given 
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that fertility status for some of the participants diagnosed with endometriosis and not 
considered to be suffering from infertility might solely be due to the fact that some of 
those participants are single and/or not sexually active. All in all, future research should 
include a significantly higher count of both cases and variables. 
Implications 
Social Change 
The findings of the study might lead to social change by adding new evidence to a 
topic within women’s health that has been considered a controversial topic for far too 
long (Kovacs, 2015).  The findings of the study are expected to provide accurate 
information for the use of disproving currently existing information and theories about 
the disease that perhaps are false/misleading. The study is expected to serve as an asset 
for supplying readers with knowledge regarding the topic, which ultimately is expected to 
better help individuals recognize and understand “normal” menstrual cycles versus 
abnormal menstrual cycles, as well as “normal” symptoms associated with menstrual 
cycles versus serious abnormal pain that can be linked to endometriosis.  The study also 
is expected to serve as evidence for why physicians should be more concerned for 
endometriosis being diagnosed carefully and more promptly.  Furthermore, in regard to 
social change, the study hopefully will be able to provide a sense of support for women 
who suffer from the disease, inspiring them not to overlook health emergencies out of 
fear or frustration that physicians might dismiss them.  Women should be made aware 
that effective treatment is available if they seek it.  The study also is expected to promote 
social change by further supporting the devastating effects of endometriosis that burden 
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women and their families since the disease currently is not recognized as a medical 
disability (Jones, 2016). In regard to the study results, specifically, social change is 
expected to be implemented by preventing infertility amongst woman who suffer from 
both endometriosis and uterine fibroids, who are at risk for infertility due to the cluster of 
endometriosis and uterine fibroids, together. In other words, preventative programs aimed 
at better educating women on the risks of endometriosis and uterine fibroids should be 
better implemented. 
Theoretical Framework 
Again, the theoretical framework for this study consisted of the General Model of 
Total Patient Delay, also known as “the Andersen Model,” which is widely used for a 
variety of disorders (Walter, Webster, Scott, & Emery, 2012). The theory suggests that 
reducing diagnostic delays may result in improved prognosis for most disorders (Walter 
et al., 2012). With that said, the Andersen Model explains important aspects regarding 
delay stages (e.g. appraisal, illness, behavioral, scheduling, treatment) and was used in 
the current study as a foundation for whether diagnosis of endometriosis poses a higher 
incidence for risk (i.e. infertility) based on age – especially upon considering the co-
variates uterine fibroids and site/location of implantation of endometrioma. The 
theoretical model also aided in the explanation of why certain time intervals exist 
between onset of symptoms of endometriosis and formal diagnosis given that the model 
suggests that diagnostic delay results from conceptual beliefs about one’s symptoms; 
behavioral factors such as strategies for self-appraisal; and techniques for coping with 
illness and emotional reaction (Walter et al., 2012). 
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Recommendations for Practice 
The findings from this study highlight the importance of earlier diagnosis of 
endometriosis opposed to later diagnosis of endometriosis in order to potentially prevent 
issues with infertility. For example, the data has shown that a statistically significant 
association exists between infertility and the age in which a woman is diagnosed with 
endometriosis, with infertility being more frequent among those aged 35 years at time of 
endometriosis diagnosis opposed to those aged 23 years at time of endometriosis 
diagnosis. Further, the findings of the study address the implications associated with the 
presence of uterine fibroids when paired with diagnosis of endometriosis, as well as 
conclusions that can be made in regard to the specific site/location of implantation of 
endometriosis when considering the odds of infertility. 
Conclusion 
Although endometriosis has been well-documented in medical texts for more than 
4,000 years and was formally discovered microscopically by Karl von Rokitansky in 
1860 (Nezhat, Nezhat, & Nezhat, 2012), the disease remains the subject of debate – 
especially over the last decade (Brosens & Benagiano, 2011). Furthermore, although 
laparoscopic procedure was introduced in the early 1960s, which stands successful in 
distinguishing three different clinical presentations of endometriosis (i.e. peritoneal, deep 
adenomyotic, and cystic ovarian) (Brosens & Benagiano, 2011), diagnosis of 
endometriosis still is found to be delayed anywhere from 7-10 years and is poorly 
recognized by physicians in practice, often leading to misdiagnosis and/or suboptimal 
care (Johnston et al., 2015). 
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Although there is reason to believe that an optimal approach to managing 
infertility requires a method associated with routine and timely measures, investigation 
concerning causes of female infertility is increasingly receiving less attention (Bell, 
2014). With that said, this study aimed to determine whether earlier diagnosis of 
endometriosis (e.g. diagnosis at an earlier age) could be considered as a preventative 
strategy towards infertility. Although currently existing literature suggests that 
suppressive medical treatment of endometriosis does not benefit fertility, the potential 
importance concerning the age of women when diagnosed with the disease never has 
been taken into consideration (American Society for Reproductive Medicine, 2012; 
Radhika et al., 2016) before this study. 
This study examined the association between infertility and the age in which a 
woman is diagnosed with endometriosis when the covariates, uterine fibroids and 
site/location of implantation of endometrioma, are taken into consideration. The findings 
from this quantitative study add support to the idea that delayed diagnosis (or diagnosis at 
a later age opposed to a younger age) is associated with higher frequency of infertility; 
further supporting claims that earlier diagnoses could be considered as preventative 
strategies against infertility. Since addressing the gap in the literature, this study has 
provided important information related to delayed diagnosis of endometriosis and how 
such delays in diagnoses are associated with higher incidence of infertility, with a 
statistically significant association existing between infertility and the age in which a 
woman is diagnosed with endometriosis after controlling for the presence of uterine 
fibroids among the study population. Findings from this study demonstrate and support 
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the importance of managing infertility by eradicating the delay that exists in regard to 
endometriosis diagnoses. 
In conclusion, applying attention to this research study is critical to the 
elimination regarding the contribution endometriosis has on the fate of young women 
potentially being faced with infertility issues. Given the findings of this study, it is 
evident that endometriosis can be eliminated as the number one cause of infertility in 
women if the delay in diagnosis of the disease, which currently exists, is eradicated. For 
example, if women being diagnosed at age 35 years could be lowered, with more 
diagnoses taking place between the ages of 18-25 years, infertility among women aged 
18-35 years, specifically, could be reduced significantly; especially given that the results 
of this study show a 62% greater odds of facing infertility based on age when diagnosed 
with endometriosis, with 20% of infertile participants in the study population being 
diagnosed at age 35 years and 0% of infertile participants being diagnosed between the 
ages of 18 and 25 years. Given that endometriosis can not be self-diagnosed, it is critical 
that physicians in practice aim to better recognize the disease. 
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